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Figure 4.13 Three resonator BPF model of the three-axis powering cage. Orange K-
inverters are set by the geometric relations of the coils L1, L2n, and L3. The blue K-
inverters are tuned using a two capacitor topology. L1 is the transmit coil, L2n is relay coil 
2a or 2b, L3 is the 20 mm diameter receive coil. ZL is the load impedance and Zi is the 





Figure 4.14 Coupling trends throughout the three axis cage. k13 is the coupling 
coefficient between the transmit and receive coils. a) Coupling in the XZ plane at Y = 0 
cm. The receive coil is moved along the dotted lines in the Z direction. Colors of the 
dotted line in the schematic correspond to the colors in the plot. Coupling is greatest near 
the coil wrappings (0, 13, 26 cm). The coupling dips between the wrappings (6.5, 19.5 
cm). These dips are the weakest coupling points when the receive coil is parallel to the 
transmit coil. The same trend is observed in the YZ plane. b) Coupling in the XY plane at 
Z = 26 cm. The receive coil is moved along the dotted lines in the X direction. The 
greatest coupling occurs at the ends (0 and 26 cm). The coupling dips toward the middle. 
The same trend is observed while moving the XY plane along the Z-axis.  c) Coupling as 
a function of angle. As the receive coil is turned from parallel to perpendicular, the 
coupling drops. At 90o, the coupling is negligible.......................................................... 130 
 
Figure 4.15 The three axis RCFET powering system. a) side angled view of cage. The 
external K inverter, K01, is boxed in blue. Three perpendicular coils are seen. Each side of 
the bottom of the cage is 12 inches. The height is 11.5 inches. b) Side view of cage. The 
arrow points to coil 1. Coil 2 wraps vertically and perpendicular to coil 1.  c) Receive 
coils and powering boards. Coil 3, the receive coil, is shown by the red arrows. K3,4 for a 
50 ohm load is boxed in blue. The devices on the left are unpackaged (middle) and 
packaged (right) versions of the wireless power measurement system. The AC voltage is 
rectified to DC and then measured with a MCU. The data is then wirelessly transmitted to 
a basestation. Sampling occurs at 2.5 kHz.  The black bar is 5 mm............................... 131 
 
Figure 4.16 Two port measurements of the powering cage for a 50 Ω load. All 
measurements are taken with the receive coil parallel to the relay or transmit coil. a) 
Measurement taken with coupling at a maximum to the transmit coil (corner location, see 
Figure 5.14).  Dotted line is the simulation case and red line is the measurement. b) Same 
as (a), but coupled to the relay coil. c) Measurement comparisons of the a strong coupling 
position (red), the middle of the cage (blue) and a weak coupling position (black) when 
coupled to the transmit coil.  d) Same as (c), but coupled to the relay coil. ................... 132 
 
Figure 4.17 Wireless powering in an animal using the three axis RCFET cage. Rectified 
voltage at the input of the regulator is shown and continuously stays above 1.8 V 
(regulator voltage). Rectified voltage fluctuates more while the animal is moving than 
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Epilepsy is a spectrum of diseases characterized by recurrent seizures. It is estimated that 
50 million individuals worldwide are affected and 30% of cases are medically refractory 
or drug resistant. Vagus nerve stimulation (VNS) and deep brain stimulation (DBS) are 
the only FDA approved device based therapies. Neither therapy offers complete seizure 
freedom in a majority of users. Novel methodologies are needed to better understand 
mechanisms and chronic nature of epilepsy. Most tools for neuromodulation in rodents 
are tethered. The few wireless devices use batteries or are inductively powered. The 
tether restricts movement, limits behavioral tests, and increases the risk of infection. 
Batteries are large and heavy with a limited lifetime. Inductive powering suffers from 
rapid efficiency drops due to alignment mismatches and increased distances. Miniature 
wireless tools that offer behavioral freedom, data acquisition, and stimulation are needed. 
This dissertation presents a platform of electrical, optical and radiofrequency  (RF) 
technologies for device based neuromodulation. The platform can be configured with 
features including: two channels differential recording, one channel electrical stimulation, 
and one channel optical stimulation. Typical device operation consumes less than 4 mW. 




constant current driver provides biphasic electrical stimulation. For use with optogenetics, 
the deep brain optical stimulation module provides 27 mW/mm2 of blue light (473 nm) 
with 21.01 mA. Pairing of stimulating and recording technologies allows closed-loop 
operation. A wireless powering cage is designed using the resonantly coupled filter 
energy transfer (RCFET) methodology. RF energy is coupled through magnetic 
resonance. The cage has a PTE ranging from 1.8-6.28% for a volume of 11 x 11 x 11 in3. 
This is sufficient to chronically house subjects. The technologies are validated through 
various in vivo preparations. The tools are designed to study epilepsy, SUDEP, and 
urinary incontinence but can be configured for other studies. The broad application of 
these technologies can enable the scientific community to better study chronic diseases 









CHAPTER 1. INTRODUCTION 
The brain is exquisite, dynamic and complex.  The hundreds of billions of 
neurons and glial cells coordinate and control our behavior. Since the classic experiments 
of Berger, Hodgkin and Huxley (1-5), and Benabid (6), the neuroscience research 
community has been in constant pursuit of better tools to study the spatial, temporal, 
electrical, and chemical attributes of normal and pathological neural systems. As a 
zealous proponent of systematic deconstruction of the central nervous system, Francis 
Crick wrote (7): 
A major first step, then, is to identify the many different types of neuron existing in the cerebral 
cortex and other parts of the brain. One of the next requirements (as discussed above) is to be able 
to turn the firing of one or more types of neuron on and off in the alert animal in a rapid manner. 
The ideal signal would be light, probably at an infrared wavelength to allow the light to penetrate 
far enough. This seems rather farfetched but it is conceivable that molecular biologists could 
engineer a particular cell type to be sensitive to light in this way. 
 
In 2005, Boyden et al., followed with the first optogenetic demonstration of 
channelrhodopsin-2 (8). Since then, the neuroscience community has seen a tremendous 
push for integrated technologies that can match the physical properties of the brain, 
capture the resolution and scale of information being acquired and delivered, correlate 




can enable medical researchers to systematically deconstruct circuits and better 
understand the mechanism of neurological diseases. The end objective is to develop cost-
effective, optimized, personalized treatments. Diseases such as epilepsy are complex, 
etiologically non-homogenous, and poorly understood. Epilepsy affects ~1% of the 
world’s population (9).   Approximately 20-30% of all cases are refractory to medication 
and the patients may be viable for surgical procedures including vagus nerve stimulation 
(VNS), deep brain stimulation (DBS), and focal brain resection. Temporal lobe epilepsy 
(TLE) is the largest category of intractable partial epilepsy with seizures predominantly 
initiating in the limbic circuitry. Owing to the success of DBS treatment in Parkinson’s 
disease (10-12), DBS has been used in hopes of seizure freedom for severely epileptic 
patients (13). Two recent major clinical trials have investigated targeting DBS therapy at 
a clinically defined focus (14) or the anterior nucleus of the thalamus (ANT)—a site 
within the classical Papez circuit (15). A Cochrane meta-analysis showed that both 
strategies were effective at reducing seizure rates, but do not have significant responder 
rates (at least 50% seizure reduction) within 3 months of the trial (16). DBS may have 
longer working mechanisms and has great promise in neuromodulation. It is clear, though, 
that much progress is needed to reach seizure freedom for epileptic patients. Further, 
severe epileptic patients are at higher risk for sudden unexpected death in epilepsy 
(SUDEP). There are currently no effective treatments. Better tools are needed to enable 
the research community. This work presents a platform of wireless technologies for use 
in rodents to study epilepsy and SUDEP, but the platform can be extended to other 
disorders such as urinary incontinence. Sections 1.5-1.7 briefly overview aspects of 




remaining chapters are standalone and can be integrated as a technology platform for 
chronic animal experiments. Chapter 2 focuses on an implantable closed loop device with 
biopotential acquisition and electrical stimulation. Chapter 3 presents published work on 
a miniature, deep brain optical stimulator for use in optogenetics, and Chapter 4 details a 
three-axis omnidirectional wireless powering system to house rodents. 
 
1.1 Wireless Devices 
Major goals in developing wireless neural prostheses involve moving towards 
more clinically relevant products, observing chronic behavior, and developing high 
throughput experimental protocols. A large portion of current rodent neural prostheses 
are based upon wired technologies which are disadvantageous due to the restrictive 
environment required by the tether, increased risk of infection from the percutaneous 
connector, and impractical implementation of large-group, longitudinal monitoring 
protocols.  Wireless microsystems obviate the tethered disadvantages and transmit 
biopotentials with greater fidelity by measuring and processing the signal close to the 
source. Devices should contain circuitry for signal acquisition and conditioning, 
stimulation, telemetry, and power management. The ideal device would be miniscule, 
dissipate extremely low powers to prevent tissue heating, have noise floors below all 
signals of interest, and deliver any number of recording and stimulation channels with 
continuous operation. There are two primary modalities in neuromodulation: electrical 
stimulation and optical stimulation in optogenetics. Electrical stimulation methods are 
clinically approved and have been used for decades. It has consumer confidence and has 




that has seen tremendous growth in the last 10 years. Optogenetics allows cell type 
specific modulation of neurons through genetic techniques and spatial selectivity of tissue 
through optical delivery systems. This is a distinct advantage over electrical stimulation, 
which can only create transient electric fields in a given volume of tissue. Recording 
technologies have been extensively developed in both academia and industry and are 
more widely available to researchers. These devices are used to monitor the time varying 
electrical potentials in tissue. Tying the recording and stimulation technologies together 
to create closed-loop systems is required to further stimulation strategies. Optimized, 
controlled, smart personalized therapy is the next frontier in neuromodulation.  
The probe tissue interface is the greatest challenge facing neuroprosthetics (17,18). 
High-density microelectrode arrays (MEA) provide high spatial resolution data revealing 
valuable insights into seizure (19-21). The most prominent probes currently used in 
research are microwire arrays, Michigan electrodes, and the Utah array. The chronic 
stability of these interfaces, though, is not robust and signals of interest degrade over time 
with large variation (22,23). The insertion of electrodes injures the brain, and a persistent, 
dynamic immune response results in poor electrode performance (23-26). Using MEA, it 
is currently difficult to achieve stable recordings of a specific neuron over a chronic time 
period (22,27). These conditions set serious limitations to experimental protocols. 
Current seizure detection algorithms use lower frequency content (< 100 Hz) that is 
chronically robust (28-31). Several strategies to stabilize microelectrode recordings are 
currently under investigation and include: insertion mechanisms for sub 25 micron 
diameter electrodes (32), conductive polymers with tissue friendly chemical and 




flexible after (34), and coating electrodes with antiinflammatory nanoparticle agents (35). 
There is no clear solution and more studies are needed to overcome the probe-tissue 
interface. The current limitations should be carefully considered during design of 
experimental procedures and associated devices. 
Heating of neurons have led to behavioral changes (36) and temperature rises in 
tissue can cause cell injury and death (37).  Device heating is proportional to power 
dissipation, and the physical transfer of heat to tissue is dependent on the heat source 
location, heat sinks, and device-tissue interface. As en example, an LED used for optical 
stimulation in optogenetics typically generates a significant amount of heat, and the LED 
can be mounted on the skull (38-40) or implanted within the brain (41,42). Heating 
should be addressed in both methods; however, the latter strategy demands more 
stringent constraints and detailed analysis. The intent of this work is not to advance the 
understanding of the device-tissue interface, but careful consideration is given to design 
and methods that allow observation of chronic biopotentials and minimize tissue damage. 
 
1.2 Electrical Closed-Loop Deep Brain Stimulation Technologies 
Wireless biopotential acquisition requires amplification, signal conditioning, 
digitization, and telemetry. In epilepsy and SUDEP, the critical signals of interest are 
seizures, the electrocardiogram (ECG), and respiration biomarkers. Acquisition units are 
capturing the time and frequency content of the signals for analysis (43-45). 
Electroencephalogram is the clinical gold standard. EEG is recorded on the scalp, and the 
signal is a summation of all extracellular current sinks and sources under the site of 




resolution, and reduced frequency bandwidth (47). The data is typically low pass filtered 
with a cutoff of 100 Hz. With animal models, depth electrodes (intracranial EEG) are 
implanted, and the resulting signal reflects the activity of a smaller population of neurons 
than the EEG with greater amplitudes, spatial resolution, and bandwidth (46,47). The 
cumulative response can be filtered to produce two signals: multiple unit spiking activity 
(MUA, highpass 300-500 Hz) and local field potentials (LFPs, lowpass 300-500 Hz) (48). 
If the electrode tip is sufficiently close to a neuronal body, single unit activity may be 
detected. LFP contributions are mainly derived from synaptic activity (46) and is an 
important band in seizure detection. The ECG reflects the electrical potential changes 
within the heart and can be measured with several lead configurations. The frequency 
content ranges up to 100 Hz. Respiration rate can be measured by a variety of techniques, 
but of particular interest to this work is external intercostal electromyography (EIC EMG). 
In rats, EIC muscles T2-T5 reflect inspiration activity, and the EMG activity has power in 
the 100-624 Hz frequency band (49). As more channels and data are required, an 
increased emphasis is placed on power consumption per amplifier data reduction 
techniques. To reduce demands on telemetry, feature extraction, such as seizure detection, 
has been used to only transmit relevant data information (50,51), which can offer 
significant (14:1) power reduction (51). Feature extraction also enables asynchronous 
telemetry to only transmit after detection (52). To quantitatively assess integrated circuit 
topologies during design, a comparison of algorithms and hardware-associated costs can 
be of great value (53-55). The size of small rodents place limits on the scale and 
architecture of implantable systems. As a result, the wireless technology specifications 




Integrated circuits (IC) are often used for proof of concept demonstrations in 
academia (28,51,56,57). Scaling these analog ICs to large animal experiments is 
challenging, as it requires a detailed analysis of the fabrication process to limit variability 
and maximize yield. Furthermore, IC fabrication, testing, and distribution are costly. It 
should be noted, though, that there are successful product contributions from academia to 
the medical research community. After many years, Reid Harrison has commercialized 
his biopotential ICs into the 16-64 channel amplifiers offered by InTan Technologies (58-
61).  Additionally, Fan et al. presented a 32 channel full system IC with a 50 kHz 
sampling (62), and Szuts et al. successfully designed a 64 channel IC with a 20 kHz 
sampling rate (63). While full system ICs will always have the most impressive 
specifications, the use of commercial off the shelf components (COTS) in device design 
can provide the needed reliability in large-scale animal experiments. Microprocessors are 
continually optimized for lower power and smaller applications. Perhaps the greatest 
advantage is that the time between iterations for COTS devices is rapid.  Currently, two 
companies provide fully implantable systems: Millar Telemetry Systems (also known as 
Telemetry Research, TR) and Data Sciences International (DSI). TR systems provide up 
to two channels of biopotential acquisition with a battery and wireless inductive powering 
(64). The product is robust but large for rats often requiring intraabdominal implantation. 
Inductive powering provides severe limitations in range and coil alignment. DSI has 
smaller telemeters with up to two channels of biopotential measurements, but the battery 
life of the devices under operation is limited (65). Both devices lack stimulation circuitry 
and cannot be modified by labs for closed-loop protocols. One academic COTS device is 




backpack, is not implantable, and consumes 31.8 to 53.4 mA of current (66). Another 
COTS device has an impressive number of acquisition channels (up to 16 at 20 kHz 
sampling) and could be mated to a stimulator for closed-loop DBS; however, it is 
prohibitively large (35 x 35 x 35 mm), non-implantable, and only has 6 hrs of battery life 
(67). The power consumption and size are not suitable for chronic, continuous 
experiments. Table 1.1 compares the current biopotential acquisition devices. It shows 
the range of specifications between IC and COTS design, and demonstrates the lack of 
suitable closed-loop devices for use in epilepsy.  
Electrical deep brain stimulation (DBS) has been FDA approved for use in 
Parkinson’s disease, movement disorders, and recently epilepsy. DBS electrodes can be 
implanted in the focus for responsive stimulation or bilaterally at the anterior nucleus of 
the thalamus (ANT) for open loop stimulation in Canada and Europe. Neither location 
offers complete seizure freedom for all patients (68). Typical output waveforms are high 
frequency (130-200 Hz), constant voltage or current, and charge balanced. The charge 
balanced biphasic waveform is needed to reverse electrochemical processes occurring at 
the electrode site (69). In rodent models, it has been observed that high frequency 
stimulation (>100 Hz) reduces neuronal excitability in the focus when compared to low 
frequency stimulation (5 Hz) (70). A study evaluating the effectiveness of DBS at the 
ANT for suppression of acute seizures observed that 100 Hz stimulation raised the 
threshold for pharmacologically induced seizures, while 8 Hz could lead to seizures (71). 
Interestingly, low frequency 1 Hz stimulation of the ventral hippocampal commissural 
white matter tract was able to reduce seizure rates from nearly 4 seizures a day to less 




Table 1.1 Current Full System Devices for Rodent Biopotential Recordings 











up to 2 
pressure 
1 7-8 or 14-
16 
32 64 
HP cutoff, Hz Not reported 0.1 0.32 4-300  0.8 10-100 
LP cutoff, Hz Not reported 145 80 3000  7000 50-4500 
Bandwidth, 
Hz 
Not reported 0.1-145 0.32-80 4-3000  0.8-7000  10-4500 
Sampling 
Rate 






50 kHz 20 kHz 
Gain, dB20 Not reported  60 54-90  58  65  
Input referred 
noise 
Not reported Not reported Not 
reported 
2.2 µV 10 µV <4 µV 








None None Yes None None None 
Device 
components 
COTS COTS COTS COTS IC IC 
Implantable? Yes Yes No No No No 
Power 
consumption 











Battery Battery Battery Battery Battery 
Battery Life, 
hrs 
4-7  2 months Not 
reported 
1.5 6 6 
Size (L x W x 
H) 














27 x 24 x 6 
mm 
35 x 35 x 
35 mm 
2.2 cm3 Head board: 
3.5 x 2.5 cm 
 
Transmitter: 






5 x 4 x 3 cm  









Two chronic DBS studies in two different rodent models of epilepsy actually showed that 
stimulation caused an increase in seizures (73,74). The variance in efficacy with respect 
to stimulation parameters across rodent studies show that successful DBS is heavily 
dependent on the seizure dynamics and location of modulation (75,76). A single set of 
stimulation parameters may not be sufficient to provide seizure freedom and 
combinatorial treatments may be needed (77). Programmable stimulation parameters are 
thus crucial in a DBS device. Importantly, none of the aforementioned rodent studies 
used a wireless, rodent implantable stimulator. As epilepsy is a chronic disease and 
human DBS patients are not tethered, animal studies should reflect the clinical scenario. 
Several wireless DBS devices have been made for rodent research (78-84). While these 
devices offer biphasic stimulation (78,80-82,84) and programmable parameters (78,80-
84), these solutions are not suitable for use in chronic epilepsy experiments due to the 
size (78,80,84), range of wireless telemetry (83), requirement of inductive powering 
pulses to shape stimulus waveform (82), and limited battery life (78-81,83,84). 
Additionally, the previous stimulators were not designed for feedback-based, responsive 
stimulation experiments. To the author’s knowledge, there is no implantable wireless 
device with the capacity to record biopotentials and stimulate responsively. Such a device 
would be of great use to the scientific community, especially in the space of epilepsy for 
on-demand treatment of seizures (85). This is a significant engineering challenge as the 
size of rodents limits the space for extensive circuitry. The devices in Tables 1.1 and 1.2 
are all too large for implantable applications and still do not include complementary 
stimulation or recording circuitry. Innovations in miniaturization are required. 




and disease experiments. Microcontroller (MCU) platforms support the implementation 
of closed loop architectures and investigation of a new space of experimental paradigms. 
This technology begins a small, but necessary step to close the larger gap between basic 
neuroscience research, neural engineering, and ultimate clinical application. Chapter 2 of 
this work presents a microcontroller centered implantable biopotential acquisition system 
and electrical stimulator. The stimulator is wirelessly programmable, miniature (for use 
in rodent experiments), and integrated into a closed-loop platform device. The device is 
validated in vivo through acute ECG, EIC EMG, and evoked potential measurements. 






Table 1.2 Current Full System Devices for Rodent Deep Brain Stimulation 





1 2 1 1 1 2 
Biphasic 
stimulation? 
Yes Yes Yes Yes No Yes 
Power Supply, 
V 
3 4.65 5 V 
compliance 
3 3 3.6 











50-120 20-100 100-500 50-600 200-500 13-1000 
Stimulation 
frequency, Hz 




time is 10 
µs 
131 1-200 2-500 
Pulse width 
duration, µs 
0-80 60 50-250 52  30-1400 0-100% of 
period 









None None None None None None 













COTS COTS COTS COTS COTS COTS 














Battery Battery Inductive 
powering 
Battery Battery Rechargeable 
Battery 
Battery Life 7 days  2 months - 3-5 weeks Not 
reported 
10 days 
Size (L x W x 
H) 
28 x 15 






14 x 22 x 6 
mm 






33 x 20 x 8 
mm 





1.3 Optical Deep Brain Stimulation Technologies 
Optogenetics utilizes molecular tools that possess millisecond temporal resolution, 
high fidelity (robust response to each input), high precision (repeatable response), and a 
lack of immunogenicity (86). The characterization of channelrhodopsins (ChR1 and 
ChR2) from the algae Chlamydomonas reinhardtii has opened a window to genetically 
encode, tag, and express the protein in mammalian neurons in vitro (87,88) and in vivo 
(89,90). ChR2 functions as a single entity and is a non-selective cationic channel 
activated by blue light (87). In a mammalian physiological environment, ChR2 can 
effectively elicit action potentials within milliseconds of the light stimulus. 
Halorhodophsin (NpHR), a microbial silencer that hyperpolarize neurons through the 
pumping of Cl-, has also been introduced into mammalian cells (91-93). Since the 
introduction of ChR2 and NpHR, rapid optimization and diversification for specific 
neuronal functions have emerged (94-97).  The potential to control specific neurons, 
determine their anatomical connections, and deem them necessary and/or sufficient for a 
particular behavior—physiological or diseased—could have serious implications in our 
understanding of the brain. 
Optogenetic studies fundamentally rely on the delivery of light to the neurons. 
Most optogenetic studies to this point have used ultra high power (UHP) lamps or lasers. 
Some have used LEDs. Anatomically, the two main classes of structures of interest are 
cortical and deep brain. To reach the targets using an UHP lamp or laser, an optical fiber 
can be coupled and implanted stereotactically with or without a guide cannula (98). LEDs 
can either be placed against a thinned skull or craniotomy to reach cortical structures.  




brain structures, an optical fiber is typically used due to the limits of light transmission 
from scattering of photons in the parenchyma (100). LEDs are advantageous because of 
the low power requirements (low forward voltage compared to lasers), long operational 
life time, narrow band spectrum (compared to UHP lamps), and lack of extraneous 
components (i.e. filters) (101). LEDs can also be pulsed at nanoseconds (102), thereby 
easily surpassing the kinetics of opsins. UHP are more advantageous due to their high 
density of optical power (103) while lasers provide highly directional and coherent beams 
of light and have thus been used in most fiber-coupled applications (41,98,104). Others 
have attempted to use two-photon systems to selectively stimulate spatially distinct 
regions, and holography (105) with digital mirrors have been tried as well. As wirelessly 
powered devices must be inherently energy efficient and lightweight, UHP lamps cannot 
be used as a light source. Laser diodes, especially vertical cavity surface emitting lasers 
(VCSEL) are attractive; however, the products are sparse in academia and industry. The 
LED is ideal because of its low profile and dimensions, low forward voltage, and low 
threshold current (106).  
The current molecular optogenetic systems have a high variance in performance 
due to several confounding factors (low conductance, trafficking, expression levels, 
delivery technique), and this makes specifications for optogenetic stimulators (OGS) 
ambiguous. It is generally agreed upon, though, that an irradiance of 1 mW/mm2 at the 
plane of the targeted neuron is required for minimal activation and 10 mW/mm2 for 
maximal activation (λ = 473 nm) (107). The optical spectrum of ChR2 peaks from 460-
470 nm (87). In attempts to quantify the amount of radiance required from the fiber tip to 




model (107) from empirical rodent brain slice data have been widely used. According to 
the Kubelka Munk model, a 200 µm core diameter fiber (0.37 NA) with 3 mW total 
power output (λ = 473 nm) can reach a depth of ~0.8 mm before falling below 1 
mW/mm2 (109). Because the models are inexact, in vivo brain tissue properties are 
difficult to acquire, and it is unknown how many of a specific neuron type needs to be 
recruited for specific behaviors, it may be best to derive the required optical radiance 
from empirical studies with behavioral outputs. Due to the variability and many 
unknowns, a wide range of programmable stimulation parameters is needed. This would 
allow psychometric curves to be determined for a given optogenetic system (110). 
An optical stimulator for optogenetics should provide enough optical power for 
cortical and deep brain structures and offer programmable stimulation parameters. There 
have been a few previously published wireless stimulators that use light emitting diode 
(LED) as a light source. The LEDs are either implanted in the brain (42) or mounted on 
the skull on top of a cranial window (39,40,111). Programmable stimulation parameters 
are critical for consistent optical output, and behavioral modifications require specific 
firing patterns (112). Further, exposure at 10 – 100 mW/mm2 (1-10 W/cm2) of optical 
irradiance for a 1 second pulse can induce phototoxicity (113,114). In other reports, the 
Deisseroth group suggest that stimulating at 75 mW/mm2 for 50 ms pulses is the upper 
limit to prevent tissue damage (104). Without optical control, tissue damage could occur. 
Two published devices cannot precisely control the optical power emitted (39,42). Deep 
brain targeting is essential for epilepsy research. The two closed-loop optogenetic studies 
targeted neurons within the thalamus or hippocampus (85,115).  This is a challenge as 




While previous devices have claimed the ability for deep brain targeting, demonstration 
is lacking (39,40,111). The most promising technology, a custom fabricated flexible and 
implantable LED interface, is not widely accessible (42). The miniaturization and design 
of a LED-based device with programmable stimulation parameters to better control and 
systematically perturb neural circuits in chronic epilepsy animal models is needed.  
Chapter 3 presents a microcontroller based deep brain optical stimulator for use in 
optogenetics. The most innovative contribution is the coupling technique as it allows the 
miniaturization of the optical power source. The device is validated in vivo with mice 
performing a conditioned place preference (CPP) behavioral paradigm. It is shown that 




Table 1.3 Current Optical Stimulation Devices for use in Optogenetics 
Device (39) (40) (42) (111) 
Light Source 
 









resolution for y 











Duration of stimulation 
(> 1 ms) 
 
Pulse width (> 1 ms) 
 
Frequency (< 500 Hz) 
Fiber? No No No No 
Deep brain 
capability 









No No Yes No 
Power 
consumption 
> 60 mW 100s of mW to 
>4 W 
3-40 mW Not reported 
Powering source Lithium batteries Inductive 
powering 
RF scavenging Rechargeable battery 
(10 mAh) 
 







< 1 cm3  without 
supercapacitor 
Rectifier board: 




0.5 mm wide 
0.25 mm thick 
14 mm x 14 mm x 10 
mm 












(CPP) in mice 
Rotations from motor 
cortex stimulation in 
mice 
 
1.4 Wireless Power Transfer Systems 
Wireless power transfer (WPT) has a storied history and has captured the 
imagination of researchers since Hertz and Tesla (116). Application of WPT to 
implantable devices is an inherent challenge and necessary technology. Powering on 
demand eliminates the need for a tether and allows devices to have lifetimes far 
exceeding the length of chronic experiments. Radiofrequency (RF) powering is the most 




Tables 1.1-3). RF powering strategies can be classified into near field, mid-field, and far-
field.  Power transfer occurs when a source generates alternating magnetic and electrical 
fields to induce currents in the receiver. Great attention must be given to requirements of 
the application as that dictates the appropriate WPT strategy and system architecture. Full 
system biomedical implants for rodents typically consume milliwatts of power, and the 
small size of the animals limits the size of the power receiver. As power transfer 
efficiencies (PTE) are typically low (< 5%), maintaining the proper impedance match 
conditions for optimal power delivery over a wide range of space and antenna 
orientations is crucial. Additionally, the WPT system must be safe. The Federal 
Communications Commissions limits the radiation and human exposure levels of radio 
waves from RF devices (117). Tissue heating and interactions are due to radiation and 
electric field components of the electromagnetic waves (118,119). Devices that use 
radiated electromagnetic fields as a powering source must be cautious of the exposure 
limits (120). One such previous device exceeded the FCC guidelines (42), and end users 
should be given proper warning. At frequencies below 10 MHz, the magnetic fields have 
little known direct interactions with biological tissues (118,121). WPT systems should 
operate below 10 MHz with primarily magnetic induction or have an extensive analysis 
showing that the exposure is safe for use (122). 
The dominant method in the near field powering is inductive powering. Energy is 
coupled through magnetic induction, and this technique is widely used in commercial 
applications. Yet with many years of development and optimization, there are few 
clinical and research products. The inherent limitation is true omnidirectional powering in 




and coil orientation in which strong induction is achieved (123,124). Transcutaneous 
energy transfer systems (TETS) have been proposed for decades (125) and clinically 
implemented with little success (124,126,127).  Inductive powering has been 
implemented in many implantable devices, but the range is typically limited to less than 
10 cm for receive coils 6 cm in diameter or less (128-131). The most extensive research 
product developed is the Enercage inductive powering platform (132). The Enercage is 
an array of overlapping transmit spiral planar coils with multiple controllers to optimize 
power transfer to the receive unit. The power transfer efficiency at a 15 cm vertical 
distance is approximately 2-3%, and the system can deliver 20 mW to a 500 Ω load at 12 
cm (132). While this is an impressive engineering solution, the platform is incredibly 
sophisticated; difficult to reproduce; limited in vertical powering range; and has two coils 
(40 and 25 mm diameters), a monopole antenna (48 mm) and a large supercapacitor as an 
energy buffer on the power receive board (132). Such a powering system is not suitable 
for chronic epilepsy experiments.  
Mid-field RF powering is a novel technique using both magnetic induction and 
electrical radiation (122,133). Potential applications include those where the source and 
receiver are approximately a wavelength apart. At this distance, efficiencies are higher 
than using inductive near field; however, the current physical setup is rigid to the 
optimized distance (122). A major advantage is the miniaturization of the receive coil. 
Recently, a ~3 mm diameter receive coil and a custom IC LED driver was implanted in a 
freely behaving mouse (134). At a distance of 15 cm and 500 mW output power (1.6 
GHz), 50 µW is received when embedded 0.75 cm deep in porcine tissue (134). While 




limited vertical range and not currently amenable for design. Designers must wait for 
simplified mathematical methods and further characterization. The far-field couples 
energy through electrical radiation and operates in the 100’s of MHz to low GHz. This 
method can power at distances much greater than the wavelength and offers more 
freedom with orientation mismatches, but the efficiencies are low (135) and not suitable 
or safe for implantable applications requiring milliwatts of power. Tissue penetration is 
shallow, and safe exposure levels set a ceiling for radiated power from the source (120). 
Strongly coupled magnetic resonance (SCMR) for wireless power transfer is a 
non-radiative, mid range powering method (136). Energy is coupled by a resonant 
magnetic field, and the physical principles are the same as inductive powering (123). The 
primary differences from inductive powering are the use of high quality factor 
components and system architectures that allow optimization of the impedance match 
condition (123,137,138). These two factors increase the range of power transfer. As 
demonstrated by Kurs et al., high power transfer efficiencies can be achieved at distances 
several times the diameter of the powering coils (136). Even with large mismatches coils 
sizes power transfer efficiencies can reach 9.1% across multiple receivers (138). This 
feature is critical as implantable devices necessitate miniaturization. SCMR power 
transfer has been quickly adopted and already seen prototypes for clinical use (139,140). 
Application of SCMR power transfer to rodent implantable devices, though, has been 
lacking. Xu et al. presented a mat-based WPT system similar to the Enercage; however, 
this was only realized through simulation for a specific distance as the interactions 
between an array of resonant coils is quite complex (141). Table 1.4 compares a selection 




epilepsy experiments would require continuous powering within the volume of a housing 
unit. According to the NIH Guide for the Care and Use of Laboratory Animals, group 
housing rats weighing 400-500 g require 60 in2/rat of floor space and 7 inches of height. 
Often rats induced with seizures are singly housed and would require more floor space. 
An 11 x 11 x 11 in3 (L x W x H) volume sufficiently house a large rat with seizures. 
None of the solutions in Table 1.4 adequately address this volume with a miniature, 
implantable receive coil. Recently, the design of SCMR powering systems has been 
greatly simplified through microwave filter synthesis techniques (142-145). By simply 
modeling a SCMR WPT system as a bandpass filter, optimal impedance match 
conditions for maximum power transfer can be met with simple and miniature circuit 
topologies (143,144,146). In particular, the resonantly coupled filter energy transfer 
(RCFET) method optimizes power transfer simply through measurement of the physical 
coil parameters (147). Using the RCFET method, Chapter 4 of this work presents an 
omnidirectional powering cage to support the technologies detailed in chapters 2 and 3. 
The powering strategy is designed and characterized with filter synthesis theory and 




Table 1.4 Wireless Power Transfer Systems 
WPT 
system 
(131) (130) (132) (134) (141) (138) (140) 
Method 
 







13.56 MHz 1.6 GHz 26.6 
MHz 





















16 x 16 
cm 
Not reported Dependent 




5.2 cm 4.8 cm unit tile: 515 
x 450 mm 
 
can add tiles 
to create 
larger area  
Cross slot 
source 5 cm 
below a tank: 
powers a tank 





























4.5 x 7.5 




~3 x 3 mm Inside 
receive 
coil 




259 mW Not 
reported 
0.5 -  4 W  500 mW Not 
reported 
~310 mW 8.1 W 
Power 
received 
50 mW 341 µW 20 mW 50 µW 1.19 – 
1.44 V;  
no load 
specified 
3.3 mW ~4.5 W 
Notes   Demonstrated 
in vivo with 
rats 
Demonstrated 




















It is estimated that over 50 million individuals across the globe suffer from 
epilepsy (9).  Epidemiological studies reveal that 20-30% of patients suffer from 
refractory or drug-resistant seizures (148).  As defined by the ILAE, epilepsy is  “a 
condition characterized by recurrent (two or more) epileptic seizures, unprovoked by any 
immediate identified cause” (149). Importantly, the pathological state can cause severe 
insults in cognitive development, autonomic function, and motor control, which lead to a 
dramatic decrease in the quality of life and possibly death.  Often, drug-resistant 
individuals will develop anxiety, depression, and other psychiatric disorders (148). 
Furthermore, epilepsy can be socially polarizing. Strong stigmas exist in certain cultures 
which lead to under diagnosis of the condition in surveillance studies and negative 
societal attitudes towards those affected (150). The CURE Epilepsy foundation estimates 
the United States spends approximately $15.5 billion annually and the cost will continue 
to rise, especially with soldiers returning from overseas conflicts with traumatic brain 
injury (151). With the profound personal, social, and economic burden of epilepsy, new 
tools are under development to better understand and treat the disease. 
Since epilepsy is a complex and diverse disease, it is important to characterize 
seizures carefully. As described by the ILAE, epileptic seizures are categorized into two 
distinct types: generalized and partial (149). Generalized seizures are thought to affect the 
entire brain from the onset. Partial seizures are believed to manifest from a local focus, 
recruit other neurons, and can possibly generalize.  Partial seizures are further classified 
into simple and complex. Individuals with simple seizures do not lose consciousness 




generalized (identifiable prior insult), and cryptogenic (unknown) and the temporal 
progression towards epilepsy is known as epileptogensis (152). Interventional strategies 
may be dependent on the stage of epileptogensis (Figure 1.1).  
 
 
Figure 1.1 Epileptogenesis. A normal brain undergoes a genetic, known, or unknown 
insult and develops into an epileptic brain. Interictal spikes are seen on EEG and 
normally do not progress to seizures. If underlying triggering factors are present, neurons 
begin recruitment and seizures result. The ictal wavefront propagates at speeds of 13-85 
mm/s in cortical rat slices (153) and 0.12 – 0.26 mm/s in human cortical tissue (21). 
 
Current therapies in drug-resistant epilepsy are surgical resections or lesions, ketogenic 
diet, the vagal nerve stimulator, and deep brain stimulation. Trigeminal nerve stimulation 
(TNS) is currently under investigation in the United States. The responder rates of the 
devices for a ≥50% reduction in seizures are widely variable, and most patients do not 
become seizure free (154,155).  Closed-loop stimulation is an old concept, though, only 
recently has a product been under clinical investigation (156).  Responsive stimulation 
aims to prevent the spread of seizures (Figure 1.1) before it recruits more neurons. 
Closed-loop stimulation may be more advantageous from a biological perspective as 
neurons can be hyper-stimulated into a refractory state termed stimulation-induced 
depression of neuronal excitation (SIDNE) (157). Additionally, from a device perspective, 




NeuroPace’s RNS clinical trial, only 46% of the patients met the 50% reduction 
responder rate (156). These results do not out perform previous open loop strategies. The 
reasons are unclear, but recent studies have shown promise. While all of the 
aforementioned treatments are beneficial to many patients, it is clear that new and 
optimized treatments are needed for complete seizure freedom. Two landmark studies 
using optogenetics demonstrated seizures could be stopped immediately upon detection 
with optical stimulation (85,115). Translating and optimizing the molecular and electrical 
based closed-loop strategies into clinical efficacy will require device-based tools for 
chronic neuromodulation. Chapters 2-4 present a platform of technologies developed 
specifically for chronic neuromodulation in rodent epilepsy models. 
 
1.6 Sudden Unexpected Death in Epilepsy 
Sudden unexpected death in epilepsy (SUDEP) is a category of death afflicting 
patients with epilepsy. Persons with epilepsy are greater than 20 times more likely to die 
unexpectedly than the general population (158), and refractory epilepsy patients are at 
even greater risks. By definition, definite SUDEP meets the following criteria (159): 1) 
sudden 2) unexpected 3) witnessed or  unwitnessed 4) if witnessed, no non-epilepsy 
related identifiable cause such as drowning 5) seizure or no seizure observed 6) if a 
seizure is observed, it cannot be status epilepticus (seizure duration ≥ 30 minutes) 7) no 
causal evidence of death during autopsy.  The mechanisms of SUDEP are poorly 
understood but are thought to include seizure related cardiac and respiratory arrest, and 
severe dysfunction of autonomic regulation through limbic, sympathetic, and 




abnormalities and that the heart rate increased more in SUDEP patients (149 beats/min) 
when compared to intractable epilepsy patients (126 beats/min) during the ictal period of 
a seizure (163). Cardiac arrhythmias are common in intractable epilepsy patients as well 
(164), and pinpointing what leads to SUDEP will require further studies. A Lack of 
respiratory drive due to seizures leads to postictal apnea, which then causes hypoxia, 
hypoxemia, and acidosis (162,165,166). A dysfunctional cardiorespiratory feedback 
system can prevent recovery and result in death (165). In a study with audiogenic 
seizures, on oxygen rich environment provided after a seizure was able to prevent 
postictal sudden death (166). Known risk factors include: poorly controlled seizures, 
using several antiepileptic drugs (AED) with little therapeutic effect, 3-12 generalized 
tonic clonic seizures (GTCS) per year, frequent long seizures, and young males (160). 
Additionally, those with genetic susceptibility to cardiac arrhythmias are more likely to 
experience SUDEP (167). Currently, there are no effective prevention measures. 
Physicians can identify those most at risk and offer precautions (161). The vagus nerve 
stimulator (VNS) could prevent cardiac instability but this is still unclear (168). It has 
been observed that SUDEP often occurs during sleep at night (163,169), so tools for 
continuous monitoring are needed. To provide more efficacious prevention and treatment 
measures, a better understanding of SUDEP is required. A key challenge is to relate 
epileptogenesis and seizure activity in specific brain regions with cardiac and respiratory 
signals in animal models. Autonomic regulation can be studied by observing heart rate 
variability with respect to other physiological measures such as breathing and blood 
pressure (170,171). As SUDEP is currently unpredictable, chronic monitoring is needed 




human phenotypes and mechanisms. Critically, miniature wireless technology provides 
an essential toolset for SUDEP researchers. Chapter 2 demonstrates a recording platform 
that allows 4 channels of biopotential acquisition to observe a combination of ECoG, LFP, 
respiratory EMG and ECG activity. 
 
1.7 Urinary Urge Incontinence 
Urinary incontinence (UI) is the inability to control the mictruition. Greater than 25% 
of women (172) and greater than 11% of men (173) 60 or older report UI. UI is divided 
into stress incontinence (external urethral sphincter dysreguation) and urge incontinence 
(bladder control dysregulation). Urge incontinence is typically more severe and requires 
medical treatment. The etiologies are wide ranging from aging to neurological disorders, 
and the symptom can cause great physical, psychological, and social discomfort. Central 
nervous system control of bladder function is regulated through the periaqueductal grey 
(PAG). The PAG is under tonic GABAergic inhibition, and when the bladder is full, 
stretch receptors in the bladder send ascending signals through the spinal cord to the 
midbrain. The PAG is disinhibited, and an efferent voiding signal is sent back down to 
the bladder for mictruition. Previously, it has been established that deep brain stimulation 
of the PAG in both rats and humans can prevent voiding in a full bladder (174). This has 
large implications for patients with urge incontinence, but before human clinic trials can 
begin, chronic device based animal studies should be pursued. Closed-loop technologies 
can be used to measure the bladder pressure and stimulate the PAG accordingly to offer 
control over the urge to void. Chapter 2 details a pressure sensing device prototype and 




CHAPTER 2. BUILDING BLOCKS FOR A CLOSED LOOP SYSTEM 
2.1 Introduction 
Wireless closed-loop devices for epilepsy are designed to gather and input information 
responsively with minimal to no side effects.  The system architecture determines the 
functional capabilities, and seamless integration of hardware blocks is necessary for 
robust full system performance. The key hardware blocks include the physical probes, 
analog front-end acquisition (AFE), analog-to-digital converter (ADC), stimulation 
circuit (electrical or optical), telemetry, and power management (Figure 2.1) 
Biocompatible, metal electrodes will be used to acquire information from a subject, and 
the electrode tissue interface must be considered during design of the input analog front 
end (AFE) (175). Delivering information or a stimulus can occur electrically or optically 
with electrodes or LEDs, respectively. Control of the stimulation parameters is critical. It 
is well known that specific stimulation protocols can provide relief in Parkinson’s disease 
(176), affect behavior (112), and selectively activate neurons (177). End users must have 
a simple way to communicate to the device, and this is executed through a graphical user 
interface (GUI) and basestation. While less glamorous in the research realm, seamless 
operation of the GUI and basestation is required for adoption by external end users. 
Wireless powering for continuous powering is an active area of research and will be 





Figure 2.1 Closed-loop system blocks for complete wireless operation. Red arrows show 
the path of information delivery to the user. Green arrows show the path of user 
controllability and blue arrows show the delivery of information to the subject. Black 
arrows show the powering path. The dotted line outlines the physical components on the 
device.  
 
A designer must always consider how all blocks of the system interact. This chapter will 
specifically focus on the device platform and the design considerations. The GUI and 
basestation are contributions of other individuals and will not be discussed. Section 2.2 
provides a brief overview of the device for closed-loop modulation. The device has 1 
channel for biopotential acquisition and 1 for channel stimulation.  Sections 2.3 and 2.4 
detail the biopotential acquisition and stimulator design, respectively. Section 2.5 briefly 
describes the MCU operation and telemetry. Section 2.6 details the in vivo validation of 
ECG, EMG, ECoG and LFP. Section 2.7 then applies the platform for pressure 




1) The design and characterization of a miniature, implantable closed-loop 
device for biopotential acquisiton and electrical stimulation 
2) In vivo application of the wireless platform in preliminary studies of SUDEP 
and urinary urge incontinence. 
 
2.2 A Miniature Closed-Loop Device for Neuromodulation 
The device platform consist of subsystems to detect and amplify biological 
signals, input a stimulus, communicate through telemetry, make logical decisions, and 
receive power. This section presents a miniature closed-loop device with 1 channel of 
biopotential acquisition and 1 channel electrical stimulation. The device block diagram is 
depicted in Figure 2.2a.  The analog front end (AFE) signal chain consists an 
instrumentation amplifier (INA) cascaded with an operational amplifier (OPA). An 8-10 
bit analog to digital converter (ADC) internal to the microcontroller (MCU) digitizes the 
amplified biopotential. The MCU packages the data for telemetry through an onboard 
radio at 2.4 GHz. The constant current stimulator consists of a current sink topology with 
dual pole, dual throw switches at the output to flip the polarity of delivered current. The 
miniature device is pictured in Figure 2.2b,c with the AFE on the top side and the 
stimulator circuitry on the bottom side. The device is 7 x 14 x 3 mm (L x W x H) and 
weighs less than 0.7 g (powering circuitry not included). Detailed descriptions of the 
circuit topologies are provided in Sections 2.3-2.5. As commercial off the shelf (COTS) 
components are used for fast iterations and widespread accessibility, the internal 
structures of the electrical systems are not focused upon. Instead, emphasis is placed on 




generation technologies for this platform. The individual subsystems used for acquisition 
and stimulation can be combined to design devices at a small size for specific 
experiments. For instance, a 4 channel recording system is used in Section 2.7 for 
preliminary experiments to study SUDEP. 1 channel stimulation device can be combined 
with biopotential acquisition blocks for closed-loop protocols.   
 
 
Figure 2.2 A miniature closed-loop device with 1 channel of biopotential 
acquisition and 1 channel electrical stimulation. a) Block diagram of the device. 
Electrodes 1a and 1b are the probes to connect the tissue to device. Two stages of 
amplification are performed. The first stage is an instrumentation amplifier (INA) and the 
second stage is an operational amplifier (OPA). Digitization of the analog signal is 




(MCU). The MCU also has a radio for two way communications with the basestation (not 
shown). The constant current stimulator is a standard current sink with switches to flip 
the polarity of stimulation. Electrodes 2a and 2b deliver the current to the tissue. For 
detailed circuit diagrams of the analog front end (AFE) and stimulator see Figure 3.3 and 
3.5, respectively. b) The top side of the device contains the AFE circuitry. The device is 
pictured with flexible cuff electrodes used in peripheral nerve modulation. XTAL is the 
crystal for the MCU. Refer to block diagram for connections. c) The bottom side of the 
device contains the stimulation circuitry. 
 
2.3 Biopotential Acquisition - Analog Front End 
Biopotentials can be found anywhere a time varying electric dipole exists. While 
the electroencephalogram (EEG) is the gold standard in the clinical workup of epilepsy 
and other neural disorders, researchers are also interested: action potentials, local field 
potentials (LFP), electrocorticograms (ECoG), electrocardiograms (ECG), and 
electromyograms (EMG). The frequency and voltage amplitude content of these signals 
are depicted in Figure 2.3 (58,178). Current rodent studies in epilepsy primarily use EEG 
and LFP signals for analysis, and the frequency content is below 200 Hz. The ECG 
frequency content is within this bandwidth, but higher frequency EMG activity can be 
observed. The electrodes being used determine the detectable EMG bandwidth. Typical 
surface EMG is limited to 500 Hz activity, while fine intramuscular probes can detect 
motor unit action potentials with frequencies over 1 kHz (179). As this work is focused 
on using EMG measurements to determine respiration rates (49), motor units do not need 
to be observed. To satisfy the bandwidth required to observe electrographic seizures, 
ECG, and EMG activity, the low pass filter is designed for 1 kHz.  If higher frequency 





Figure 2.3 Frequency content and amplitudes of common biopotentials.  
 
In a typical signal chain, each set of electrodes interfaces with a differential amplification 
scheme. After the first stage of amplification, often termed preamplification, the signal is 
high pass filtered to remove any slow potentials or DC offsets. A second stage of 
amplification is used for increased gain, and the low pass filter prevents aliasing. The 
resulting signal is digitized and transmitted. The signal chain from electrode output 
(amplifier input) to digitization is termed the analog front end (AFE). The purpose of the 
AFE is to differentiate the signal from noise; it must have the ability to measure a specific 
electrical marker that correlates to a physiologically relevant event. Figure 2.4 shows a 






Figure 2.4 AFE features. (Top) Typical features in a generic amplifier chain. (Bottom) 
The AFE specific to the closed-loop device. An input filter limits radiofrequency 
interference and an instrumentation amplifier (INA) is the first gain stage. A high pass 
filter removes DC offsets and then an operational amplifier (OPA) serves as both the 
second stage of amplification and anti-aliasing low pass filter. The ADC in the MCU 
digitizes the amplified signal.  
 
To maintain signal fidelity, additional important design features of the AFE are listed in
Table 2.1. A detailed circuit schematic is provided in Figure 2.5. This schematic will be 
used to explain features and design choices. The AFE uses a cascaded amplifier topology 
with input and output filters (Figure 2.4-5). The electrode inputs are configured 
differentially and connected to an INA. Input filters between the electrodes and INA are 
used and component values are carefully implemented to minimize conversion of 
common mode to differential signals. The INA rejects common mode noise and provides 
preamplification. The second stage amplifier provides further amplification and signal 
conditioning. The topology only requires 2 physical connections to the subject and is 
considered ground free—no ground electrode is connected to the subject (180).  This can 






Table 2.1 Analog Front End Design Specifications 
Design Parameter Specification Reason 
Input impedance Hundreds MΩs - GΩs To prevent voltage division 
and observe activity at point of 
electrode. Exact impedance 
needed depends on electrodes 
used. 
CMRR 80 dB Rejection noise, primarily 
from main power lines (50 or 
60 Hz) 
Low input-referred noise < 10 µV To observe small signals 
Gain 60 dB (1000:1) Amplify and increase 
resolution 
Input dynamic range 35.56 dB  Measure wide range of signal 
amplitudes (20 µV-1.2 mV) 
Size <5 x 10 mm2  Miniaturization 
Power consumption < 280 µW/mm2 
 
 
Prevent heating of biological 
tissue. Minimize as much as 




Figure 2.5 Circuit Topology of Analog Front End. INA = instrumentation amplifier, OPA 
= operational amplifier, MCU = microcontroller, ADC = analog to digital converter, 





2.3.1 Input Impedance 
Input impedance of the INA is ideally infinite to prevent voltage division with the 
electrode. There are two input impedances, the differential, Zdm, and common mode, Zcm. 
The differential impedance must be large to maintain signal integrity, and the common 
mode impedance should be sized to minimize noise. The reported input impedance, 
typically differential, of most clinical amplifiers used in epilepsy centers is 10-50 MΩs 
(181). Electrode impedance is frequency dependent, changes over time, and variable 
between electrodes. From 1 Hz and 2 kHz, microelectrode impedances can range from a 
few MΩs to 10 kΩs, respectively (182). Geddes et al. reported that faithful EMG 
recordings could be acquired with input impedances ranging from 1 to 88 MΩ for 
stainless steel electrodes having areas of 500 to 125000 µm2 (183). More recently, it was 
suggested that at least a 1 GΩ input impedance is required to prevent signal distortion of 
lower frequency content when microelectrodes are used in the clinic (181).  Achieving a 
1 GΩ input impedance with limited space is not always practical, though. For instance, 
the state-of-the-art Intan Technologies RHD2000 chip has a 13 MΩ input impedance at 1 
kHz. Unfortunately, commercial devices from Telemetry Research and DSI do not report 
the input impedance specification. In Figure 2.5, the INA used is the INA333 since it has 
a differential input impedance of 100 GΩ (184). The common mode impedance, though, 
is determined by input biasing resistors, R3 and R4, and filtering capacitors, C1 and C2. 
Here, the discussion will be focused on the resistor values as the capacitors are set to 100 
pF to minimize RF interference (Section 2.3.4). The resistors are required to center the 
input signal, and since Zdm is essentially infinite compared to Zcm, common mode signals 




and R4 are not large with respect to the electrode impedance, then mismatches in 
electrode impedances will result in larger contributions from common mode to 
differential signal conversion (potential divider effect, Section 2.3.3) (186). This will 
degrade the signal quality by introducing noise. In this work, 10 MΩ bias resistors with a 
1% tolerance were chosen since the power line noise contribution is simulated to be a few 
µVs with a CMRR of 80 dB (Section 2.3.3). Novel topologies should be investigated to 
further decrease noise contributions in low power, two-electrode topologies. 
 
2.3.2 Common Mode Rejection Ratio and Differential Gain 
The common mode rejection ratio (CMRR) is the ratio of differential gain, Ad, to 
common gain, Acm (equations 2.1-3). A high CMRR amplifies differential signals while 
minimizing common mode signals. Impedance mismatches in the internal circuitry cause 
common mode signals to appear differential, and this will lower the CMRR.  External 
components at the input of the INA (R1-4 and C1-2) can also severely degrade CMRR; 
this is known as the potential divider effect. To demonstrate, a 10 pF capacitance is added 
to C2, which creates a 10% mismatch between C1 and C2 (Figure 2.5). Figure 2.6 shows 
a greater than 20 dB decrease in CMRR due to the 10 pF mismatch (red trace). The 
potential divider effect does not reduce the differential gain (Figure 2.7), so it is 
important to measure the common mode gain to detect CMRR degradation. By selecting 
well-matched (within 1%, NP0 temperature rating) input resistors and capacitors, a 
CMRR of 100 dB at 60 Hz is achieved (blue trace, Figure 2.6). The CMRR is measured 
using a dynamic signal analyzer. First, the differential gain is measured by applying a 




common mode voltage source (input terminals connected together). The gain is the ratio 
of Vout over Vin. Vin is either the differential input voltage, Vdm, or the common mode 










  (2.3) 
 
 
Figure 2.6 High common mode rejection ratio (CMRR) is achieved with well-matched 
components and degraded with mismatches. Cascaded amplifier topology was used with 
1% matched components (blue). Potential divider effect is observed when 10 pF is added 















The cascaded amplifier topology allows the gain to be distributed in order to maintain 
bandwidth and eliminate undesirable DC offset voltages. Electrode-tissue interactions 
create DC-potential offsets that can saturate the INA if the gain is too high (187). The 
first stage gain is designed for 20 dB (10:1) and measured at 19.99 dB (Figure 2.7, black 
trace). With a supply voltage of 1.8 V, the tolerable electrode offset voltages are less than 
180 mV.  The high pass filter eliminates any DC offsets. The second stage gain is 
designed for 40 dB (100:1) resulting in a total gain of 60 dB (Figure 2.7, blue trace). The 
total gain is 59.43 dB which is in good agreement with design. The high pass filter is 
controlled by R5 and C3. The low pass is controlled by R7 and C4.  The respective 3 
dB cutoffs are 0.72 Hz and 1.13 kHz. The 3 dB cutoff frequency, fc, can be calculated by 












Figure 2.7 Gain and bandwidth of the analog front end. Three conditions were measured 
to observe how component addition affected the differential gain. Black = INA333 + the 
input low pass filter, blue = cascaded amplifier topology with input filter, red = cascaded 
amplifier topology with 10 pF mismatch at the input filter (see Figure 3.6 for CMRR 
degradation). High pass 3 dB cutoff frequency = 0.72 Hz, Low pass 3 dB cutoff 
frequency = 1.13 kHz. Cascaded amplifier (blue) gain = 59.43 dB in the pass band. 
 
2.3.3 Power Line Noise Reduction 
Noise is introduced to the analog front end by magnetic induction and capacitive 
coupling of electrical fields (186). From Faraday’s Law, conducting loops allow 
magnetic fields to induce an electromotive force (emf). The resulting emf pushes current 
and creates noise. Alternating electrical fields displace charges in the electrode leads and 
subject’s body. This also results in noise. Typically, the 50 or 60 Hz main power line is 
the primary noise source; however, in a wireless powered system, it is important to 




will first be addressed. Figure 2.8 is the circuit representation of noise coupling into a 
two-electrode ground free circuit topology (180). Equation 2.5 represents the total noise 
at a specific frequency that is seen by a differential amplifier as depicted in Figure 2.8 
(186). The total current seen by the subject’s body due to the power mains coupling 
through C1 is represented by id1. The KBS term represents noise from magnetic induction. 
K is a constant, B is the magnetic flux density, and S is the loop area that allows magnetic 
induction.  The ib1Ze1 and ib2Ze2 terms represent the voltage noise caused by capacitive 
coupling into the leads. Ze1 and Ze2 represent the impedance of each electrode and ib1 and 
ib2 are the currents passing through each branch. Zb is the impedance of the subject’s 
body and ib is the current flow in the body.  The current from id1 can flow to earth ground 
through the subject, id2, or through the common mode impedance (Zcm1 or Zcm2) of the 
INA, id3 (typically 1 nA) (180). The final term reflects the voltage noise due to current 
flowing through Zcm. The bracketed portion shows the effect of the CMRR and potential 
divider effect. The KBS term can be ignored by minimizing conducting loop area with 
short connections, shielding, or twisting the electrode leads. This reduces the S term to a 
negligible value (assume S = 0). Previously, it has been shown that the currents through 
the electrode and Zb are relatively small and can be neglected (180,186). Assuming that 
the common mode impedance of the INA is much greater than the electrode impedances 
(assume Zcm >> Ze), then remaining factors are the common mode impedance, CMRR, 
and potential divider effect. Thakor and Webster previously derived the simplified 
equation for a ground free, 2 electrode telemetry configuration (equation 2.6) (180).  Zd 
represents the mismatch between electrode impedances, and Zcm1 and Zcm2 are assumed to 










Figure 2.8 Circuit representation of a two electrode ground free biopotential recording 
system. Noise from main power lines is coupled through C1 resulting in a current id1. This 
current can then flow through the electrodes and be seen by the device, (ib1, ib2, id3) or 
flow to the earth ground (id2). See equations 3.5 and 3.6 for the quantification of the noise. 
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From equation 2.6, the voltage noise contributions from the common mode impedance 
can be simulated for various CMRRs (5 kΩ electrode impedance mismatch, id3 = 1 nA, 
Figure 2.9). In typical instrumentation amplifier settings, it is beneficial to have both a 
high common mode impedance and differential impedance. Importantly, in a ground free, 
2-electrode configuration, the Zcm can increase the noise for a particular CMRR and 
electrode-tissue impedance mismatch (Figure 2.9). This is not an intuitive result and 
should be carefully considered. Having an infinite CMRR would minimize the noise, but 
this is not realistic, especially when size and power are considerations for INA selection.  
Understanding the minimum noise requirements and potential electrode mismatches 
defines the CMRR required. Figure 2.10 shows how increasing mismatches in electrode 
impedances affect the voltage noise (CMRR = 80 dB, id3 = 1 nA). The closed-loop device 
CMRR can range from 80-100 dB depending on the input filter matching (Figure 2.6). 
With a 5 kΩ electrode impedance mismatch and 80 dB CMRR, the voltage noise due to 







Figure 2.9 Voltage noise versus common mode impedance. Simulation data from 
equation 2.6. A 5 kΩ electrode impedance mismatch, Zd, is used. CMRR from 40 to 100 
dB are plotted.  
 
 
Figure 2.10 Voltage noise versus common mode impedance for various electrode 
impedance mismatches, Zd. Simulation data from equation 2.6. 80 dB CMRR is used. Zd 




2.3.4 Minimizing Radiofrequency Interference  
Radiofrequency wireless powering of devices introduces a planted noise source 
directed at the implantable device. Amplifiers in particular are susceptible to RF 
interference at the electrode inputs. If seen by the INA, frequencies in the MHz manifests 
as DC offsets and slow drifts. This behavior exists because amplifier inputs act as diodes 
in this frequency range and rectify the AC signal into DC or slow AC waves (188). This 
can be observed by directly inputting a high frequency differential signal into the INA 
inputs. To demonstrate, a signal generator is used to input 1, 10 and 20 MHz differential 
signals into the INA with no input filters and only input common mode bias resistors 
(Vdd = 3.0, gain = 43 dB (200:1)).  Additionally, a reference voltage of 1.5 V was 
applied to the output through a unity gain buffer. The output voltage should be centered 
at 1.5 V. Figure 2.11 plots the average output voltage detected by an oscilloscope as the 
amplitude of the input signal is varied. The output voltage shifts well beyond 1.5 V, and 






Figure 2.11 DC offsets and slow drifts caused by RF inputs into the INA. A function 
generator inputs 1 (blue), 10 (red), and 20 (black) MHz signals into the input of an INA 
with no filtering. The measured output is the average as observed on an oscilloscope. Vdd 
= 3 V and the output reference voltage is 1.5 V. 
 
To minimize the RF induced drifts, a low pass input filter is inserted using C1, C2, R1, 
and R2 (Figure 2.5). Due to the potential divider effect, the components must be well 
matched. Low pass filters require smaller valued components than high pass filters. It is 
reasonable to find 1% matched COTS passive components with small footprints to 
prevent CMRR degradation. The benefit of the filter is shown in Figure 2.12. The full 
analog front end was used for this measurement (Vdd = 1.8 V, Gain = 60 dB). A 1, 4, and 
8 MHz differential signal at various amplitudes is applied at the inputs with the signal 
generator. These frequencies are used since the wireless powering (Chapter 4) is 
performed at 4 MHz. The common mode output voltage is 0.6 V at 100 mV pk-pk input. 
For ease of viewing, the common mode output voltage is shifted to 1.6 and 2.6 V for the 
500 mV and 1V conditions, respectively.  The input filters remove the DC offset and 





Figure 2.12 Prevention of DC drifting due to RF interference. A low pass filter was 
inserted into the inputs of the device AFE. A waveform generator is used to pass 100, 500 
and 1000 mV pk-pk into the device. The data is digitized and transmitted. The common 
mode output voltage is 0.6 V, but the results have been level shifted for 500 and 1000 
mV pk-pk signals. This was done for ease of viewing. No DC offsets or drifting is 
observed. Device gain is 60 dB 
 
2.3.5 Input Referred Noise 
The smallest signal the AFE can measure is determined by the device’s internal 
noise. Instrumentation amplifiers have an input voltage noise source, output voltage noise 
source, input current noise source, and other external noise sources (i.e. electrodes or 
biasing circuitry). The total noise referred to the INA input can be quantified by 
equations 2.7 and 2.8 (189). The voltage noise source at the input, eni, is not affected by 
the gain, G, of the amplifier, while the voltage noise source at the output, eno, is. The 
current source at the input, in, creates noise with respect to the electrode resistance, Re. 




an approximate noise value referred to input is calculated to be 56.92 nV⋅Hz-1/2. Figure 
2.13 shows the measured noise at the output of the second stage of analog front end (blue 
line). The noise referred to input is determined by dividing the total output noise by the 
gain (black line). At 20 and 200 Hz, the noise referred to input is 68.15 and 49.16 nV⋅Hz-
1/2, respectively.  Values are well matched to theoretical calculations.  To observe the 
minimum noise seen by the device, the electrode inputs of the device are shorted and the 
resulting voltage is digitized by the MCU. The baseline oscillates between 2 or 3 bits, 





Table 2.2 Noise Referred To Input Parameters 
Parameter Definition Value 
eni (10 – 1000 Hz) Voltage noise source at 
input 
50 nV⋅Hz-1/2 
eno (G = 10) Voltage noise at output 200 nV⋅Hz-1/2 
In (max) Current noise source at 
input 
100 fA⋅Hz-1/2 
Re,i (i = 1,2) Electrode resistance 10 kΩ 
Vn,external = resistor thermal noise 
 
kB = Boltzmann’s constant 
 
T = temperature 
 
Thermal noise  13 nV⋅Hz-1/2 per resistor 
Vn,total  Total noise 56.92 nV⋅Hz-1/2 
 
€ 




















Figure 2.13. Total output noise (blue) and noise referred to input (black) of analog front 
end. The cascaded amplifier topology is used and noise is measured at the output of the 
second stage amplifier (input to the ADC). A dynamic signal analyzer is used with 100 
sample averages. 
 
2.3.6 Final AFE Specifications 
The ADC within the microcontroller performs the digitization of the amplified 
and conditioned signal. The ADC can operate with 8, 9 or 10-bit resolution and operates 
with an internal 1.2 V reference. For a fixed gain of 60 dB (1000:1 ratio), the voltage 
resolution is 4.69 µV, 2.34 µV, and 1.17 µV for 8, 9 and 10-bit resolution, respectively. 
Typically, the 8-bit resolution is used. If 60 dB of gain and no noise are assumed, the 




be detected before saturating the ADC is 1.2 mV. As the noise floor seen by the device is 
2 to 3 bits, detectable signals are greater than 14.07 µV. Thus, the dynamic range is 38.61 
dB. The AFE occupies 7 mm x 7 mm of board space, and with telemetry, the area is 
increased to 7 mm x 14 mm. The device draws 1.8 mA RMS (1.8 V Vdd) which equates 
to a power consumption of 3.3 mW. The measured specifications of the analog front end 
can be found in Table 2.3. It is difficult to compare the AFE of this device to other COTS 
or commercially available devices since several of the product specifications are 
unreported (Table 2.4). Three important features standout, though. 1) This is the first 
implantable biopotential telemeter to offer electrical stimulation for closed-loop 
applications. 2) The size and power consumption are significant advancements from 
previous devices. When compared to the only non-implantable biopotential telemeter 
with stimulation (66), the size is reduced from 37 x 26 x 6 mm and 27 x 24 x 6 mm to a 7 
x 14 x 3 mm and the weight from 4.44 g to less than 0.7 g (batteries and wireless 
powering not included). 3) The device presented is not limited by battery life and can be 
used for chronic applications. 
Table 2.3 AFE Measured Specifications 
Design Parameter Specification 
Input impedance 100 GΩ (from INA333 datasheet) 
CMRR 80-100 dB 
Low input-referred noise 68.15 nV⋅Hz-1/2 (20 Hz) 
 
49.16 nV⋅Hz-1/2 (200 Hz) 
High Gain 60 dB (1000:1) 
Input dynamic range 38.61 dB  
Size 7 x 14 x 3 mm (includes 
telemetry)  








Table 2.4 Comparison of AFE to COTS and Commercial Devices 











, up to 2 
pressure 
1 7-8 or 14-
16 
1 
HP cutoff, Hz Not reported 0.1 0.32 4-300  0.72 
LP cutoff, Hz Not reported 145 80 3000  1132 
Bandwidth, Hz Not reported 0.1-145 0.32-80 4-3000  0.72 - 1132 







Gain, dB20 Not reported Not reported 60 54-90  60 
Input referred 
noise 
Not reported Not reported Not reported 2.2 µV ~2.3 µV 






None None Yes None Yes 
Device 
components 
COTS COTS COTS COTS COTS 
Implantable? Yes Yes No No Yes 
Power 
consumption 
Not reported Not reported 31.8-54 mA Not 
reported 
3.3 mW 
Powering Source Rechargeable 
battery; inductive 
powering 




Battery Life, hrs 4-7  2 months Not reported 1.5 No battery 








37 x 26 x 6 mm 
 
MCU board: 
27 x 24 x 6 mm 
35 x 35 x 
35 mm 
7 x 14 x 3 
mm 
Weight, g 13  8  4.44 (not 
including 
battery pack) 





2.4 Constant Current stimulator 
The function of a constant current stimulator is to deliver information to neurons 




waveforms, safety under fault conditions, and controllable parameters (pulse width and 
amplitude).  The stimulator topology is a current sink with switches to control the 
polarity (Figure 2.14) (190). A blocking capacitor is placed between one electrode and 
the switch to limit charge injection under fault conditions, maintain charge balance, and 
block DC currents (191,192). Additional blocking capacitors can be placed at each 
electrode as a safe practice. MCU timers are used to control the pulse width and 
frequency of stimulation while a digital to analog converter (DAC) outputs a reference to 
control the current amplitude.  
The stimulator topology maintains a constant current by the feedback to the 
operational amplifier. When switch A connects the Vref and Va nodes, the operational 
amplifier will drive the MOSFET until Vb = Va. Since Vb is equal to Vsense, the amplitude 
of current can be controlled with Vref  and is equal to Vref / Rs. Given enough voltage head 
room to drive the load across the electrodes, the current will be held constant at the 
desired amplitude. The first generation topology can drive 1.316 mA across a 1.026 kΩ 
load (Figure 2.15). The MCU control logic of stimulation parameters is shown in Table 
2.5. During the initialization, no current is passed. At event 1, the switches are configured 
to pass current through the electrodes in one polarity and then toggled at event 2 to flip 





Figure 2.14 Constant current stimulator topology. The opamp wil drive the MOSFET 
until Va = Vb. Current amplitude can be calculated by dividing Vref by Rs. An additional 
DC blocking capacitor can be placed on electrode 2. Blue label indicates blocks that are 
controlled by the MCU. Switch operation is detailed in Table 2.5. 
 
Figure 2.16 demonstrates fast stimulation at 1 kHz with 200 µs pulse widths. The 
frequency of pulsing is much greater than the typical deep brain stimulation paradigm 
(100-200 Hz). As some applications require more headroom to pass more current, a 2nd 
generation stimulator is designed that can handle a 12 V supply. The increased supply 
voltage provides voltage headroom to pass a minimum of 1 mA through a 10 kΩ load. 
Figure 2.17 compares the driving capabilities of the 1st and 2nd generation stimulators 
across a 10 kΩ load. The differential voltage measured in Figure 2.16 and Figure 2.17 
were acquired with an oscilloscope probing the voltages at the output of electrode 1 and 






Figure 2.15 Linear control of current of constant current stimulator. Rs = 497.8 Ω, Vdd = 2 
V, Rload = 1.026 k Ω. The current plateau is 1.316 mA. 
 
 
Table 2.5 Control Logic of Stimulation Parameters 
 Initial Event 1 Event 2 Event 3 
Electrode 1 Vdrain Vdd Vdrain Vdrain 
Electrode 2 Vdrain Vdrain Vdd Vdrain 






Figure 2.16.  Biphasic stimulation pulse train. Stimulation is across a 11 kΩ load. 
Stimulation parameters are: 200 µA, 200 µs pulse width, 1 kHz period. Differential 
voltage is the voltage across the load. 
 
 
Figure 2.17 Comparison of the 1st generation and 2nd generation constant current 
stimulators.  The first generation stimulator (black, left) is driving a 10 kΩ load with 200 
µA (100 µs pulse width). The second generation CCS (blue, right) is driving a 10 kΩ 





2.4.1 Final Constant Current Stimulator Specifications 
The measured specifications of the constant current stimulator are shown in Table 
2.6. Programmable features include pulse width, frequency, current amplitude, and 
duration of stimulation. Experimental DBS protocols range from 1 Hz to 200 Hz 
stimulation (72-75). The maximum driving current is determined by the load and voltage 
headroom provided by the stimulator supply voltage (Vdd). As previously discussed in 
Section 3.3.1, electrode impedances can vary significantly in vivo. Clinical DBS 
macroelectrodes range in impedance values from 500-1500 Ω (193). Microelectrodes, 
though, can have impedances in the tens of kΩs (182). Increasing the voltage headroom 
for the 2nd generation stimulator allows experimenters to drive 1 mA across a 10 kΩ load, 
exceeding the typical drive currents of a few hundred µAs. Table 2.7 compares this work 
to other COTS implantable stimulators from Table 1.2. For brevity, non-implantable 
devices are not included. This work meets the specifications of other COTS stimulators, 
and excels in size and operating lifetime, as it does not rely on batteries. While it does not 
provide 2 channels of stimulation, this device includes a biopotential acquisition channel 
for closed-loop operation. It is difficult to compare current driving capacity as loads are 
not specified in other works. The measured specifications show that the CCS presented in 




 Table 2.6 Final Specifications of the Constant Current Stimulator 
Parameter Condition Specification 
Minimum Pulse width  8 µs 
Frequency  1-10 kHz 
Stimulation current  Rs = 499 Ω   
Vdd  = 1.8 V Rload = 1 kΩ 1.2 mA 
Vdd  = 2 V Rload = 1 kΩ 1.3 mA 
Vdd  = 3 V Rload = 1 kΩ 2.0 mA 
   
Vdd = 12 V 
(2nd generation) 
Rs = 200 Ω 
Rload = 10 kΩ 1.0 mA 
Biphasic Stimulation  Yes 
   
Footprint (L x W x H)  6 x 5.5 x 3 mm 
 
Table 2.7 Comparison of CCS to COTS and Commercial Devices 
 
Device 





2 1 1 2 1 
Biphasic 
stimulation? 
Yes Yes Yes Yes Yes 
Power Supply, 
V 
4.65 5 V 
compliance 
3 3.6 1.8 – 12 V 






Yes; wireless Yes; tethered Yes; wireless 
Stimulation 
current, µA 
20-100 100-500 50-600 13-1000 120 – 1000 







time is 10 
µs 
131 2-500 1-10000 
Pulse width 
duration, µs 
60 50-250 52  0-100% of 
period 
8 µs to 100% 
of period 
Telemetry No No Yes; inductive 
near field 
communication 





None None None None Yes 










































Battery Life 2 months - 3-5 weeks 10 days - 







14 x 22 x 6 
mm 
20 x 38.5 x 
13.5 mm 
33 x 20 x 8 
mm 
6 x 5.5 x 3 
mm 





2.5 Microcontroller and Telemetry 
An ARM Cortex-M0 Nordic microcontroller (MCU) acts as the brain of the device. 
The MCU digitizes the output of the AFE and telemeters the data. The devices are 
configured with a total sampling rate of 5 kHz. The telemetry is setup to transmit 40 kbps 
and the MCU can support up to 2 Mbps (194). Similar to the firmware for the optogenetic 
device (Chapter 3), interrupt based logic is used to maintain low power consumption and 
sleep states. The fidelity of telemetry with respect to range and orientation of the antenna 
is an important consideration. By designing at a miniature scale, the manufacturer 
recommended antenna circuit board layout technique must be modified. To quantify 




with respect to the basestation (Figure 2.18). The packet loss is measured over 20 second 
intervals. The packet loss is less than 3% in most orientations and distances and less than 
1 % in orientations 1 (in line, blue) and 2 (perpendicular, grey) at a distance of 12 inches. 
Packet loss is the worst with orientation 1 at 48 inches (12.5% loss) and position 3 
(standing) at 24 inches (4.3% loss). To better understand losses in future iterations, the 
antenna radiation pattern should be measured in an anechoic chamber. 
 
Figure 2.18 Packet loss with respect to distance for 3 device orientations. The device is 
parallel and inline (blue), perpendicular (grey), or standing (black) with respect to the 
basestation. Losses were measured at 12, 24 and 48 inches.  
 
2.6 In vivo validation 
Validation of device blocks in vivo is performed acutely and chronically in rats. 
All procedures were approved by the Purdue Animal Care and Use Committee (PACUC) 
under protocol 1112000339. For acute experiments, female adult Long-Evans rats were 
anesthetized with urethane (0.7-1.2 mg/kg, IP) and given butorphanol (0.5-2mg/kg, SC). 




respiration rates, LFP, and EEG or ECoG. Subsections of 2.6 will address each 
biopotential measurement. EEG and ECoG are categorized together as the frequency and 
amplitude content are similar.  
The devices used for validation are a 1st generation device with 1 channel 
recording and 1 channel stimulation, and a 2nd generation device with 2 channels of 
recording and 1 channel of stimulation. The 1st generation device is characterized in 
Sections 2.1-2.5 and will be named device 1 (D1). The 2nd generation device is an 
extension of this work and will be named device 2 (D2). A DC power supply provides 
power at 1.8 V for both devices. The bandwidth of D1 is designed for 0.7 Hz to 1 kHz, 
while the bandwidth for D2 is 8 Hz to 1 kHz. Gain for both devices are set to 60 dB. Both 
devices are sampled at 2.5 kHz per recording channel. A GRASS amplifier (GA) is used 
for comparison. Various GA gain and bandwidth settings were used to observe the 
desired signal of interest. The GA low pass cutoff was always set to 10 kHz and sampled 
at 20 kHz. For the LFP validation, D2 is used to both stimulate and record to demonstrate 
both functionalities in the device. 
 
2.6.1 Electrocardiogram in vivo Validation 
Stainless steel leads are placed intramuscularly the lead 1 configuration (Figure 
2.19). After suturing in the leads to prevent displacement, the leads are fed to a connector. 
The connector is used to exchange input connections between the GA, D1, and D2. 
Simultaneous measurements are not made to prevent undesired loading between 
amplifiers. Figure 3.19 compares the lead 1 ECG recording between the GA, D1, and D2. 




3 acquisition systems for a 7 second recording (left) and a 1 second recording (right). The 
P wave, QRS complex, and T wave are all distinctly visible in all 3 recordings. The QRS 
distortion (M shaped-wave and lower amplitude) seen in the GA recording is caused by 
the 60 Hz input notch filter and can be avoided in future experiments by switching off the 
filter. In the 7 second D2 recording, a slow ~0.5 Hz oscillation is observed. This is a 
motion artifact associated with the breathing rate of the subject. Due to D1’s lower 
highpass filter, this signal is seen in D1 and not D2.  Interestingly, the heart rate 
decreases from D1, to GA, to D2, which is the order of recording. In 7 seconds, the 
number of heartbeats is 25, 21, and 19 for D1, GA, and D2, respectively. While urethane 
anesthesia should maintain steady cardiopulmonary physiology (195), cardiac depression 
has been previously observed (196). D1 and D2 are both suitable for ECG acquisition in 
vivo. 
 
Figure 2.19 ECG Lead 1 Measurement Setup. The GRASS amplified (GA) uses 3 
electrodes. Two differential (blue) and a common mode (green) electrode. Device 1 (D1) 






Figure 2.20 Comparison Between Acquisition Systems. Lead 1 recordings from a 
GRASS amplifier (GA), Device 1 (D1), and Device 2 (D2). 7 second recordings are 
pictured on the left and 1 second recordings on the right. Leads are sutured 
intramuscularly and switched between amplifier systems. The order of recordings is D1, 





2.6.2 Electromyogram in vivo Validation 
Respiration rate activity can be observed by measuring the EMG of the external 
intercostal muscles (49,197). Stainless steel leads are placed intramuscularly in the right 
external intercostals. The same connector setup for ECG validation is used (Section 
2.6.1). Figure 2.21 shows EMG and ECG recordings at the mid-thoracic right external 
intercostal muscle. The order of recording was GA, D1, and then D2. The GA’s high pass 
was increased to 10 Hz to eliminate motion artifacts that are visible in the raw D1 trace 
(blue). No digital filtering was required on the GA. D1 and D2 have noisier recordings 
and are both high passed at 100 Hz with a digital second order butterworth filter. Raw 
traces for D1 and D2 are shown in blue, and post filtering is in black. The high pass filter 
drops the signal common mode to 0 V. The signal quality of the GA is superior. The 
common mode electrode of the GA provides increased noise rejection. However, the 
EMG signature is still observable by D1 and D2. From this data, it can be seen that 





Figure 2.21 External intercostal EMG’s recorded by the grass amplifier (GA), device 
1(D1) and device (D2). For D1 and D2, the blue signals are raw and the black signals are 
high pass filtered at 100 Hz. The high amplitude spikes are QRS complexes. The left 
figures show 9 seconds of data while the right displays only 3. The EMG activity can be 
detected with all three measurement systems.  
 
2.6.3 ECoG Evoked Potentials in vivo Validation 
To observe cortical neural activity, the EEG or ECoG is often used. Cortical 




electrically stimulated. Evoked potentials have been used to map pathways in epileptic 
patients (198), and the method is used here to elicit cortical activity for observation. The 
cingulate cortex is a downstream site of the classic Papez circuit (199) and should be 
activated by stimulation at the fimbria or fornix. In this validation experiment, a stainless 
steel bipolar twisted pair of recording electrodes is placed at the surface of the left 
cingulated cortex (AP: 1 mm, L(left): 0.5 mm, DV: -1 mm from skull surface; bregma 
reference). A bipolar stainless steel bipolar twisted pair for stimulation is targeted at the 
fimbria-ventral hippocampal commissure white matter tracts (AP: -1.3, L(left): 0.2 mm 
DV: -4.5 mm from brain surface; bregma reference). A commercial stimulator was used 
to activate the fimbria-ventral hippocampal commissural axons (3 Hz stimulation, 200 
µA, 200 µs pulse width). Figure 2.22 compares the evoked potentials at the surface of the 
left cingulated cortex. The recording progression was GA, D1, and then D2. The D2 
recording had a large amount of 60 Hz noise. As a result, a digital IIR notch filter was 
used. The raw data is shown in blue and the filtered signal in black. It seems that larger 
evoked potentials are observed in D1 and D2 when compared to GA. Figure 2.23 shows 
each evoked potential from a trial aligned and then averaged (thicker black line). It is 
clear that the GA plot has a lower amplitude. It is possible that as the GA was used first 
for recording, sufficient time had not passed to recruit neurons for a larger response. In 
all 3 recording systems, evoked potentials can be seen 3 ms after the stimulation artifact 
(aligned at 10 ms, Figure 2.23). In D1 and D2, a valley is seen at 15 ms after the 
stimulation artifact, and then second peak at 30 ms (Figure 2.23, overlay, red and blue). 




response is different. As evoked responses can be experimentally difficult to maintain, 
future setups should simultaneously record the same signal. 
 
Figure 2.22 Evoked potentials recorded by the grass amplifier (GA), Device 1(D1) and 
Device 2 (D2). Electrodes were placed at the surface of the left cingulated cortex. A 
commercial stimulator was used to activate the fimbria-ventral hippocampal commissural 
axons (3 Hz stimulation, 200 µA, 200 µs pulse width). The left figures show 10 seconds 
of data while the right only 0.8 seconds. The blue traces are raw data in all three figures. 







Figure 2.23 Averaged evoked potentials from Figure 2.22. Evoked potentials were 
aligned and averaged. The GA is recorded first, then D1 and then D2. Bottom right 
overlays the averages for each recording system (GA = black, D1 = blue, D2 = red).  
 
2.6.4 LFP Evoked Potential in vivo Validation 
The local field potential can be observed using depth electrodes. Using a similar 
setup to Section 2.6.3, evoked potentials are recorded at the ventral hippocampus (AP: -
5.2 mm, L(right): 4.5 mm, DV: -5.5 mm from brain surface; bregma reference). 
Stimulation is at fimbra-ventral hippocampal commissural axons (same as Section 2.6.3). 
In this validation, Device 2 is used to both stimulate (200 µA, 200 µs pulse width) the 




evoked potentials recorded at the right ventral hippocampus. The data is notch filtered to 
reduce 60 Hz noise. Each color represents one evoked potential and the thicker black 
trace is the average response. The peak is 30 ms after end of stimulation. The D2 
stimulation caused the amplifier to saturate and any earlier peaks are missed. This data 
shows that the 2nd generation stimulator can deliver sufficient current to the tissue, and 
that the same device can record the response shortly after. 
 
 
Figure 2.24 Evoked response recorded using only D2. The fimbria ventral hippocampal 
commissural axons are stimulated. The response is recorded in the right ventral 
hippocampus. The data is notch filtered to reduce 60 Hz noise. The peak is 30 ms after 
end of stimulation. 
 
2.6.5 Multichannel Chronic in vivo Validation 
The closed-loop device can be redesigned into a 2-channel biopotential device. 




for preliminary experiments in SUDEP. A RF wireless powering board is mounted next 
to Device A (Figure 2.25). The power board has a coil receiver that couples energy from 
a larger source coil. The RF energy coupled is rectified into a DC source. Capacitors (not 
shown in Figure 2.25) smooth the voltage, and a 1.8 V linear dropout (LDO) regulator 
provides a stable power supply to both Device A and Device B. The powering board and 
Device A are implanted on the rat’s flank and leads are routed subcutaneous and sutured 
intramuscularly in lead I and lead II ECG configurations. Device B is routed 
subcutaneous to the skull and measures LFP from the left ventral hippocampus and 
ECoG from the contralateral motor cortex. Twisted pair platinum electrodes are used for 
the LFP and stainless steel bone screws for the ECoG. The transmit powering coil is a 
single solenoid wrapped around a cage. An example dataset is shown in Figure 2.26. This 
experiment was performed in collaboration with Professor John Jefferys at the University 
of Oxford. In Figure 2.26, it is clearly shown that 2 implantable devices can 
simultaneously acquire 4 channels of biopotentials. This is crucial for experiments in 







Figure 2.25 Fully Implantable Device for Multichannel Biopotential Acquisition. a) The 
RF wireless powering receiver circuitry consists of an inductor antenna fed to a rectifier. 
The rectifier converts the RF signal is converted to a DC voltage. Capacitors (not shown) 
buffer the rectifier output and a single 1.8 V regulator creates a stable supply for Device 
A and Device 2. Device 1 acquires 2 lead configurations of ECG and Device B acquires 
ventral hippocampal LFP and ECoG from the contralateral motor cortex. b) Image of the 
powering circuitry tied to a Device 1. The star marks the coil receiver. The green board is 
Device 1 and the yellow board is the powering circuitry. The black wires provide power 
to Device 2 (not pictured). The coil is 15 mm in diameter. The black bar is 5 mm. 
 
Figure 2.26 Chronic in vivo Validation of Multichannel Biopotential Acquisition. 4 
channels of biopotentials are simultaneously acquired from 2 implanted devices. Clear 





2.7 Pressure Monitoring for Urinary Urge Incontinence 
Urinary incontinence is the inability to control the bladder. Previously, it has been 
shown acutely that the bladder can be controlled by deep brain stimulation in the 
periacqueductal grey (PAG) area in both rats and humans (174). Before pursuing chronic 
human studies, chronic animal validation studies are required. The proposed closed-loop 
system would measure bladder pressure and stimulate based upon a threshold to prevent 
urination. As a proof-of-concept experiment, a device development board was 
reconfigured to operate with a Bremen capacitive pressure sensor. When pressure is 
exerted on the membrane of the sensor, the distance between the end plates is reduced. 
This results in a detectable change in capacitance. For the experiment, the capacitive 
pressure sensor and development board are used to monitor acute changes in bladder 
pressure in an anesthetized rat. The Bremen pressure sensor (now owned by Protron 
Mikrotechnik) and measurement IC are provided by the manufacturer. For integration 
into the device platform discussed in previous sections, the packaged sensor and 
measurement IC can communicate to the Nordic MCU with already available general 
purpose digital input output pins. Figure 2.27 shows the surgical setup. An infusion pump 
delivers saline into the bladder at a rate of 6 mL/ hr. A reference sensor and the capacitive 
sensor are measuring pressure from a T piece of tubing. A GRASS amplifier monitors the 
EMG of the external urethral sphincter and the experimenter visually monitors the urine 
output. The urine output is recorded with a clicker and the entire voltage pulse indicates 
urine output from start to finish. Figure 2.28 shows the experimental data. First, both 
sensors are shown to be linear in the 0-40 mm Hg pressure range. The capacitive sensor 




data). As can be seen, the smoothed data shows the features of the raw data. As saline is 
infused, the pressure in the bladder increases. A critical threshold is reached and then the 
EUS activates and urination occurs. The data from the experiment is in good agreement 
with previous animal experiments (174). The platform is able to detect this reliably and 
integration into a device form for closed-loop control of urinary incontinence is possible 
with the presented technologies.  
 
Figure 2.27 Surgical setup of the in vivo experiment. The Bremen sensor is connected to 
the device (development board). A tube runs from the bladder to the sensor and is air 
filled at the base to prevent fluid entry into the device. The same tube is split to a 
reference sensor. The device samples at 54 Hz and wirelessly transmits the data to the 
basestation. The reference sensor is sampled at 500 Hz by the data acquisition unit 
(DAQ). A grass amplifier sampled at 500 Hz measures the EMG from the external 
urethral sphincter, and a visual detection is used to mark periods of urination. An infusion 






Figure 2.28 Pressure sensing in vivo validation. a) Air chamber calibration data for a 
capacitive sensor (black) and reference sensor (red). The pressure was increased with a 
custom manometer. Capacitive sensor data points are 20 point averages and were 
measured by a LCR meter (Agilent) with 1 MHz, 1V excitation. b) In vivo pressure 
measurements with the capacitive sensor require smoothing. The blue trace is raw data 
sampled at 54 Hz. The black trace is a moving average with a 54-sample window. The 
smoothed data agrees with the raw data trends. c) A trial observing an empty bladder 
slowly fill and increase in pressure until urination is observed. d) A trial observing the 
bladder continually urinate. In vivo bladder pressure from the reference sensor (red) and 
capacitive sensor (black) are in good agreement in both (c) and (d). The pressure drops as 
urination occurs and the external urethral sphincter activates. The pulse width of the urine 
markers (blue) indicates the total time of urination. The first mark is the beginning of the 
trial. EMG data is collected with a grass amplifier sampled at 500 Hz. 
 
2.8 Conclusion 
The platform technologies for sensing of electrical signals and providing electrical 




create a useful and flexible platform for researchers to investigate wide ranging 
neurological and psychiatric diseases in rodent models. For use in epilepsy, optimization 
of closed-loop electrical stimulation to increase efficacy and understanding the important 
features needed in seizure suppression is of great need. To the author’s knowledge, the 
first implantable device with 1 channel biopotential acquisition and 1 channel stimulation 
is presented. In SUDEP, preliminary experiments show that with two devices, 4 channels 
of biopotentials can be simultaneously acquired chronically. This experiment paradigm 
can help to address mechanistic questions involving sudden death. For urinary urge 
incontinence, pressure sensing in vivo is demonstrated acutely. Integration of the sensor 
into the device for chronic implementation is the next step in creating a closed-loop 
device to control mictruition.  
The individual building blocks of the analog front end, constant current stimulator 
and microcontroller are modularly integrated into a family of 1st generation devices. With 
slight modifications to the circuitry to reduce size and share resources, other device 
systems can be designed for specific applications. Additionally, the optical stimulator for 
use optogenetics (Chapter 3) can be driven with the CCS. A wireless, closed-loop optical 
stimulator for use in optogenetics would be of great use to the research community. Table 
2.8 lists a family of devices based on the core technologies presented and the possible 
applications. Applications in blue have been studied or are currently under study with 







Table 2.8 Family of Devices and Possible Applications 












• On board 
MCU 
• Current per phase of 
stimulation 
• Frequency of stimulation 
• Duty cycle of stimulation 
• Duration of stimulation 
• Feedback algorithms 
• Feature detection 






• LED based 
stimulation 




• On board 
MCU 
• Stimulating current 
amplitude 
• Frequency of stimulation 
• Duty cycle of stimulation 
• Duration of stimulation 
• Feedback algorithms 
• Feature detection 





• Same as DBS-CL but 






• LED based 
stimulation 
 
• Same as OGS-CL but 
without feedback or 
feature detection 
Recording only • 1-2 channels 
differential 
recording 
• Tie two 
devices 
together for 4 
channels 
 
• Parkinson’s disease 
• Epilepsy 
• SUDEP 
• Vagal nerve 
stimulation (VNS) 
















CHAPTER 3. A MINIATURE, FIBER-COUPLED, WIRELESS DEEP-BRAIN 
OPTOGENETIC STIMULATOR 
The data and work in this chapter is accepted for publication in the IEEE Transaction of 
Neural Systems and Rehabilitation Engineering (PMID: 25608307) . The citation can be 
found in the CV. This chapter is primarily a reproduction of the publication and has been 
reformatted for the dissertation © 2015 IEEE (200). This work was performed in 
collaboration with Dr. Simon John and Dr. Da-Ting Lin at The Jackson Laboratory. 
 
3.1 Introduction 
Optogenetics is a powerful core methodology for dissecting neural circuits (201). 
Pairing of miniature and wireless optoelectronic systems can enhance the rapidly 
expanding optogenetic (202) and electroceutical (203) toolboxes. In this work, a novel 
optogenetic stimulator (OGS) is presented for use in rodents. This is a lightweight, 
miniature, expandable, power efficient, wireless and low cost device to offer control of 
stimulation parameters with demonstrated deep brain targeting in rodents. Pairing of this 
technology to a biopotential acquisition device (Chapter 2) would allow closed-loop deep 
brain optical stimulation. The stimulator is expected to allow many experiments that are 
not currently practical. Section 3.2 details the modular hardware blocks. Section 3.3 




behavioral test. Section 3.4 follows with a brief discussion, and Sections 3.5-3.7 focus on 
the materials and methods. The novel contributions from this work are: 
1) A new, low profile fiber coupling technique  
2) A wireless platform technology for deep brain optical stimulation 
3) One of the earliest demonstrations of behavioral modification in mice due to 
wireless deep brain optical stimulation with optogenetics 
 
3.2 The Optogenetic Stimulator 
The OGS is a modular solution (3 modules: optical, control, and power) that 
consists of a cranially mounted fiber-coupled LED, an ultralow power microcontroller 
(MCU) to control stimulation protocols, a wireless link to trigger stimulation, and 
rechargeable solid-state batteries (Figure 3.1a).  
 
3.2.1 The Optical Module 
Targeting of deep brain structures is essential to the study of behavior (112,204) 
and disease (e.g. Parkinsonian circuitry (201) and epilepsy (85,115)). The optical module 
achieves this by coupling an optical fiber (core diameter = 200 µm; numerical aperture = 
0.39) to an LED (Figure 3.1c,d). Since optical throughput is limited by the relatively 
narrow acceptance angle (numerical aperture) and small surface area of the optical fiber, 
previous tethered LED fiber-coupled strategies had poor coupling efficiencies and 
required a driving current of 1.0 A for 27 mW/mm2 irradiance (465-485 nm) (99). With 
the presented fabrication methods, the same irradiance level can be achieved while 




irradiance level readily activates channelrhodopsin-2  (requires 1 mW/mm2 of 473 nm 
light (8)). 
 
Figure 3.1 The optogenetic stimulator (OGS) modules and full system. a) Block diagram 
of the OGS. The Passive radio (dashed line) can be removed if not needed. Solid-state 
batteries in parallel with a capacitor is used to provide continuous power. A MCU and 
current driver are used to control the LED stimulation protocol. Red = power module, 
black = control module, blue = optical module. b) A rendering of the OGS fully 
connected. c) Connecting the 3 modules: power, control, and optical. The optical module 
is depicted with corner cut away to show the coupling of the LED to fiber-ferrule. Inset is 
a cross sectional perspective of the optical module. d) Control modules for wireless (left) 
and internal triggering (middle). Since the internally triggered device does not require a 
passive radio, the antenna and rectifier are removed from the device. This makes the 
control module even smaller. The optical module (right) with a fiber-ferrule directly 
coupled to a LED. MCU = microcontroller. CCD = constant current driver. For 
alternative module configurations, see Figure 3.2. Side view of wireless control module is 




LEDs are used due to the form factor, narrow emission spectrum, rapid rise time 
(nanoseconds), consistent light output, lifetime, and safety. Since the surface area ratio of 
the fiber to LED package is < 1, the most efficient optical coupling is achieved by 
directly butting the fiber to the light source (205). This is realized with a modified fiber-
ferrule approach.  A circularly packaged, reverse mounted LED is embedded in a printed 
circuit board (PCB) and a shaved ferrule is mounted through the opposing side (Figure 
3.1c). This novel module is fabricated with two concentric through holes of differing 
depths (1.5 mm and 0.75 mm) and diameters (1.25 mm and 2.00 mm, respectively) to 
align and hold the fiber and LED. Temperature at the bottom (ventral) surface of the 
optical modules adjacent to the optical fiber only increased by ≤ 0.80 oC under different 
conditions that are far more exacting than those used in the in vivo validation experiments 
below (Figure 3.3d, e), and temperature changes at the skull would be considerably less.  
To the author’s knowledge, this is the first cranially mounted optical module with LED-
fiber coupling to allow power efficient, tether free, deep brain targeting. 
 
3.2.2 The Control Module 
Controllable optical stimulation enables more sophisticated stimulation protocols. 
It allows desired setting of various frequencies, pulse widths, irradiances, and patterns. 
The control module is designed for user programmability of stimulation algorithms and 
management of power consumption. An ARM Cortex-M0 MCU is interfaced with a 
constant current LED driver to offer control over the frequency (Figure 3.3b), pulse width 
(Figure 3.3c), and optical irradiance of stimulation. The optical and temporal parameters 




optical output power is linearly proportional to the input driving current to the LED 
(Figure 3.3a), the digitally programmable constant current driver (14 steps from 1.8 – 
20.0 mA) predictably controls the optical irradiance emitted from the optical fiber. 
During periods with no stimulation, the device turns off all unneeded MCU peripherals 
and enters a deep sleep state consuming less than 7 µA (3.3 V supply, < 23.1 µW). 
Within a stimulation train, the MCU is awake during stimulation and is in sleep for the 
remainder of the period.  Deep sleep wake up times are dependent on MCU 
configurations (0.056 – 7.0 ms; see NXP Application Note AN11027). Internal MCU 
timers or an external wireless trigger from the passive radiofrequency receiver (Figure 
3.2a) can wake the MCU from deep sleep for stimulation. Using the internal timers, in 
vivo validation was performed with looping algorithms for periodic trains of stimulation 
(deep sleep wake up time = 7.0 ms).  
 
3.2.3 The Power Module 
Ultra-low power consumption and low duty cycle operation open avenues for a 
variety of powering strategies. Previous optogenetic device studies have used RF 
radiative far field powering (42), inductive powering (40) or coin cell batteries (39) 
individually. Here, a more robust technology for behavioral experimental paradigms is 
used: rechargeable solid-state batteries that are non-cytotoxic, lightweight and thin 
(Cymbet Corporation). Two 50 µA-Hr batteries were stacked in parallel to provide 
current to the device. A tantalum capacitor delivers the surge currents required during the 







Figure 3.2 OGS modularity allows various configurations. a) 2.4 GHz monopole antenna 
(black arrow) used with a rectifier and comparator to trigger the MCU. This is a side 
view of wireless control module shown in Figure 3.1d. Additional ceramic capacitors 
(black asterisk) are placed next to the bottom connector. b) Supercapacitor modification 
for the power module. Two supercapacitors (14 mF, white arrows) stacked in series. This 
module can be used in certain experiments if more charge needs to be delivered than the 
tantalum capacitor can provide. White asterisk = Power connector. c, d) Optional surface 
mount package, 8mm x 8mm) used instead of bare die (5.7mm x 6.1mm).  The surface 
mount package is slightly larger but easier to fabricate (see Figure 4.3f for comparison to 
bare die package). e) Plot of capacitor values versus pulse current at various pulse widths. 
Blue = 2 ms, black = 10 ms, red = 20 ms, aqua = 80 ms. f) Recharge time required 
specific capacitor values with various numbers of batteries, Recharge voltage = 4.1 V. 
Blue = 1 battery, black = 2 batteries, red = 3 batteries, aqua = 4 batteries.  Scale bars a = 
5 mm; b = 2 mm. 
 
Capacitor sizing can be designed for a single or train of current pulses. This is critical in 
providing the proper current and stimulation frequency (Figure 3.3e, f). Designing for a 1 
s train of 4 ms pulses (10 mA, 20 Hz), a single continuous pulse of 80 ms as a worst case 
is assumed (see Section 3.5.3). The within train pulse rate is limited by the MCU wake up 
time and not the capacitor. The minimum capacitor was 795 µF and 1 mF was used. With 




provided. Additionally, recharge occurs between pulses. The batteries provide allow 
closed experimental setups that are not RF compatible can be used. Miniature and 
lightweight systems are critical for use in rodents to allow freely moving behavior. When 
completely connected, the OGS configuration used for in vivo validation is 12 x 7 x 11 
mm3 (L x W x H) and weighs <1.6 g. The mice are freely moving and unrestricted 
(Figure 3.3f, g). 
 
 
Figure 3.3 OGS characterization for control of stimulation parameters. a) Irradiance of 
optical modules (n = 41) with respect to input current. Solid black line = average, grey 
shading = 95% confidence intervals, dotted lines = maximum and minimum. 
Measurements made with PM100D (Thorlabs) power meter. b) Controlling stimulation 
frequencies with the microcontroller (MCU) and constant current driver (CCD). 
Normalized amplitude is the analog response of the power meter from an uncoupled LED 
connected to the control module. Green = 50 Hz, blue = 30 Hz, black = 20 Hz. 20 pulses 
each. c) Controlling pulse widths with the MCU and CCD. Each trace is a single pulse at 
20 Hz. Black = 2 ms, red = 3 ms, blue = 4 ms, green = 5 ms. d, e) heating from bottom 




width, 20 mA; e: 20 Hz, 10 ms pulse widths). Measurements were made at room 
temperature (22-24 oC).  Dotted lines are least square regressions. Error bars are standard 
errors. f) OGS used for in vivo validation on freely behaving mouse. Since wireless 
triggering was not needed, the smaller internal triggering control module was used, g) 
Mice can be grouped housed. 
 
 
3.3 In Vivo Validation 
Device validation in vivo was performed using a well-validated three chamber 
conditioned place preference (CPP) paradigm (112,206). Mice were generated that 
express ChR2-H134R and tdTomato in dopaminergic neurons after activation by Slc6a3-
cre (Figures 4.4-5). Slc6a3-Cre+ mice (treatment groups) and Slc6a3-Cre- mice (no ChR2 
expression, control groups) were implanted with optical fibers in the right ventral 
tegmental area (VTA; coordinates AP: -3.44, L: 0.5, DV: -4.1) (Fig. 3.3.1). Phasic, burst 
stimulation in this region is established to cause place preference (42,112). Mice were 
conditioned over 3 days. The control and power modules were first connected and then 
plugged into the optical module immediately prior to the conditioning sessions. 
Stimulation (20 pulses, 20 Hz, 2-4 ms pulse width, 5-10 mA, 1 minute period) was 
provided only in the afternoon. While input current controls the optical irradiance, the 
optical dose is also dependent on the pulse width and is described as output energy per 
pulse (optical power multiplied by the pulse width). The OGS was programmed to 
achieve a specific range of doses (Figure 3.6a). At various irradiances, pulse widths from 
1 to 1000 ms have been shown to elicit action potentials (8) and drive behavior 
(38,42,112). We tested the ability to drive place preference with two groups (treatment 
group 1, Tx1, lower dose range and 2, Tx2, higher dose range). Only the higher dose 




= 13.3983, p = 0.00008, Tx2 significantly different to all other groups with Tukey-
Kramer post-hoc, α = 0.01) and significantly greater post-test preference (F3,18 = 9.2681, 
p = 0.0006, Tukey-Kramer post-hoc, α = 0.05) (Figure 3.6c, d). Critically, in treatment 
groups, the post-test preference for the conditioned chamber increased with dose (Figure 
3.6f), and activity levels were not significantly different between groups (F3,18 = 1.2971, 
p = 0.3059) (Figure 3.6b) or between the pretest and post-test (Figure 3.7). These results 
are consistent with previous tethered optogenetic CPP experiments (42,112).  
 
 
Figure 3.4 Histological characterization of optical fiber implants.  a) Optical fiber 
placement at the right ventral tegmental area (VTA). The black arrow points to the VTA 
(shaded blue) and the red circles show the placements of individual optical fibers. b) 
histological characterization with c-fos staining for neurological activity after 1 hour of 
the CPP stimulation protocol (20 Hz, 10 mA, 4 ms, 20 pulses per minute). The black 
asterisk indicates the optical fiber lesion tract. Red box indicates the implant site (VTA). 
Blue box indicates enlarged view in c. c) Enlarged view of blue box in b. White arrows 
point to c-fos positive neurons indicating recent neural activity. Bar = 50 µm. d) Confocal 
image of IBA1 (green) and tdTomato (red). As is typical for implantations, IBAI shows 
mild microglial activation immediately adjacent to the fiber lesion tract (brighter green).  
As expected following Slc6a3-cre activation, the tdTomato is localized at the VTA 
(white arrow). White asterisk indicates fiber lesion. e) Enlarged view of white box in d 




(CAG COP4*H134R/TdTomato); Slc6a3-cre mice, see Figure 3.5. Scale bars a,b 1mm; c, 




Figure 3.5 Histological characterization of B6.SJL-(CAG 
COP4*H134R/TdTomato);Slc6a3-cre mice. a) tdTomato (Red) expressed in axon tracts 
(white asterisk). b) tdTomato expressed in soma (white arrows) and dendrites. c) DAT, 
dopamine transporter, antibody labeling (green) in the VTA.  d) Slc6a3-cre activated 
tdTomato (red) in the VTA. This overlays with DAT in c to infer expression of ChR2-





Figure 3.6 Dose dependent induction of conditioned place preference. a) Optical dose 
range and mean for each group (n = 4-8 per group). b) Posttest activity. There was no 
difference between groups (one-way ANOVA, F3,18 = 1.2971, p = 0.3059). c) Change 
(posttest – pretest) in preference towards conditioned side. Tx2 preference change was 
significantly different to all other groups (one-way ANOVA, F3,18 = 13.3983, p = 0.00008, 
Tukey-Kramer post-hoc, α = 0.01). All other groups were not significantly different from 
each other (TK post-hoc, α = 0.01 and 0.05). d) Posttest preference. Tx2 preference was 
significantly different to all other groups (F3,18 = 9.2681, p = 0.0006, TK post-hoc, α = 
0.01 for Ctrl1 and Tx1, α = 0.05 for Ctrl 2). All other groups were not significantly 
different from each other (TK post-hoc, α = 0.01 and 0.05). e) Posttest preferences versus 
optical dose for all control groups. Red open circles = Ctrl 1, blue open circles = Ctrl 2. f) 




1, blue closed circles = Tx 2. All error bars show standard errors unless indicated 




Figure 3.7 CPP results. a) Boxplot of post-test activities in the CPP experiments. The 
lower outlier in the Ctrl group (Ctrl 1) was excluded from analysis due to non-exploratory 
behavior. b) Activity during the pretest (dark grey) and post-test (white). There was no 
difference in activity between pretest and post-test for all groups (paired Student’s t-test). 
c) Preference score for pretest (dark grey) and post-test (white). All error bars are 
standard errors. For statistical analysis between groups, see Figure 3.6. 
 
3.4 Discussion and Conclusion 
The OGS is compatible with current behavioral assays in rodents. It offers user 
defined stimulation protocols, controllable optical dosing, wireless triggering, and deep 




the first untethered optogenetic device to successfully drive behavior dependent on deep 
brain structures with a fiber-coupled LED. Recently, Hashimoto et al. developed a novel, 
battery-powered, multi-LED stimulator with wireless infrared control of stimulation 
parameters (duration, frequency, and pulse width) (111). The device was demonstrated in 
vivo with transcranial stimulation. For targeting intracranial structures, the authors 
coupled a 0.5-1 mm diameter optical fiber and could produce 1.9 mW/mm2. This device 
does not allow control of the optical power and is a relatively large optical fiber if it were 
to be used in deep brain structures.  Importantly, the OGS can control the optical dose by 
programming the control module. With a 200 μm diameter fiber, an irradiance of 27 
mW/mm2 (21.01 mA) is achieved. The modular OGS design allows for rapid 
improvements and expansion. As a result, the device serves as a platform to integrate RF 
circuitry (207) (Chapter 4) to recharge the solid-state batteries or replace them in fully 
implantable implementations, incorporate an electrical stimulator, and add front-end 
sensors (56,208), signal processing (28) for closed-loop experimental paradigms (85,115), 
and aspects of other MCU based optical stimulators (40,111). Importantly, we used 
commercially available components, so the OGS can be widely accessible. The schematic, 
suggested PCB layout, fabrication, and basic code for the MCU are made available by 
request.  The future of novel, miniature devices, such as the OGS, is promising. 
Technological advances paired with the proper molecular tools enable new experimental 
designs in modern neuroscience research and have far reaching implications for the study 





3.5 Materials and Methods – Device Fabrication 
The optogenetic stimulator (OGS) was designed and fabricated using a host of 
equipment and software packages. The device layout for the printed circuit board (PCB) 
was developed using Osmond PCB software. PCBs were fabricated in house with a 
milling machine (ProtoMat S100, LPKF, Tualatin, Oregon, USA or Accurate 350, 
Accurate CNC, Inc., Fort Wayne, IN, USA). All PCBs were populated with components 
using a combination of reflow and hand soldering. Populated PCBs were cleaned with 
acetone and then isopropyl alcohol or methanol. 
 
3.5.1 Optical Module 
The optical module was fabricated on FR4 printed circuit boards (59 mil thickness, 
106394-1, LPKF). Two different sized through holes were drilled into the board to mount 
the ferrule and LED. From the topside of the board, with a 1.20 mm diameter drill bit 
(hole ~1.25 mm), the first through hole was made. From the same side, with a 2.00 mm 
diameter drill bit, the second through hold was made halfway through the board. Due to 
process variations, the 2.00 mm diameter hole may not always be deep enough and this 
can be corrected by manually extending the through hole with the drill bit. 1.25 mm 
diameter zirconia ferrules (Thorlabs) were cut with a diamond-crusted dremel blade, and 
stripped 200 um diameter optical fibers were inserted into the shortened ferrule and 
sealed with epoxy. The fiber-ferrule was then polished using previously described 
protocols. First, a low insertion force connector (CLE-105-01-G-DV, Samtec, New 
Albany, IN) was populated. Then the LED (PointLED, OSRAM, Munich, Germany) was 




from the bottom side. Medical grade epoxy was used to add mechanical stability to the 
ferrule-PCB connection. A diamond tipped pen was used to score and break the optical 
fiber to the desired length. Variation in coupling efficiency of the optical module (Figure 
3.3a) has potential to alter optical output for a given driving current. Low efficiency 
modules required a higher input current to provide the same optical output as a high 
efficiency module. 
 
3.5.2 Control Module 
The control module was fabricated on FR4 PCB (22 mil thickness, 108761, LPKF, 
Garbsen, Germany). The topside was populated with the microcontroller (MCU, 
LPC1104UK, NXP, Eindhoven, Netherlands; 2.2 mm x 2.3 mm) and constant current 
driver (ZLED7012, ZMDI; 2 mm x 2 mm). Low insertion force connectors are used to 
attach the optical and power modules. This architecture allows the design of low duty 
cycle operation. Untethered devices benefit from carefully designed stimulus waveforms, 
where the duty cycle is minimized without decreasing the desired modulation of neural 
activity, in order to reduce power demands and increase lifetime of operation under a 
given power budget (135). For example, when calculating with a safety factor of 2, the 
duty cycle used during in vivo experimentation was less than 0.3%. The safety factor 
doubles the calculated duty cycle. This provides a conservative estimate for design. 
Wireless triggering is implemented by passively rectifying RF signals at 2.4 GHz (Figure 
4.2). This is similar to a previous wireless stimulator design (42); however, power 
demands are much less for our design since the rectified signal is only driving the trigger 




the necessary power to drive the LEDs. The RF power link calculations are detailed 
below. When the wireless trigger is not needed, it can be removed. 
The Friis transmission equation (209) (Equation 3.1) can be used to estimate the 
power budget of a wirelessly powered RF system in the far field. Often, the log (base 10) 
format (Equation 3.2) is preferred since simple addition and subtraction can be used. 
Here we use the log form and report power values in dBm and antenna gain in dBi. The 
equations are  
  (3.1) 
 
  (3.2) 
 
where,  = Power received at the input to the rectifier;  = Power transmitter from the 
RF power amplifier into the transmit antenna;  = Gain of the transmitting antenna;  
= Gain of the receiving antenna;  = wavelength (2.4 GHz = 0.125 m);  = distance 
from transmit antenna to receive antenna (1 m). 
The power required at the input of the rectifier (1 meter distance) is determined by 
power required at the comparator input and the efficiency of the rectifier. The input 
power to the comparator is given by:  















log(Pr ) = log(Pt )




























where,  = Power;  = Current;  = Voltage across the load (input to the 
comparator); = Resistance of the load. The threshold voltage is 0.2 V and the load is 
1 MOhm; therefore, the input power is 43.98 dBm (40 nW).  In actuality, slightly less 
power will be required since the bias current into the comparator is 10 nA 
(www.maximintegrated.com/datasheet/index.mvp/id/5823). This creates a 0.01 V offset. 
Assuming a conservatively low rectifier efficiency of 25% (-6 dBm), the required power 
received at the input to the rectifier is -37.98 dBm (160 nW).  Equation 2 can be 
rearranged to solve for the required power transmitted (log(Pt) + log(Gt)). Assuming a 
receiving antenna gain of -10 dBi, the required transmitted power is 12.07 dBm, well 
below the Federal Communications Commission (FCC) maximum effective isotropically 
radiated power (EIRP) of 36 dBm (4 W) for ISM bands (FCC, Part 15—Radio frequency 
devices, Title 47, CFR 15; http://www.ecfr.gov/). There is a nearly a 24 dBm (251.1 mW) 
buffer to account for other mismatches.  
 
3.5.3 Power Module 
The power module was fabricated on 22 mil thick FR4 PCBs.  Surface mount 
(QFN package, 8 mm x 8 mm) or bare dies (5.7 mm x 6.1 mm) of the solid-state batteries 
(CBC050, Cymbet, Elk River, MN) were used (Figure 3.1-2). For the surface mount 
batteries, each battery was soldered to a PCB. Two battery-mounted PCBs were then 
physically stacked and connected. Mechanical stabilization was achieved by threading 













The die battery module consisted of more complex fabrication procedures. First 
the pads of the bare dies were stud bumped with a wire bonder. One gold wire bond was 
made to each pad of the battery. The floating tails (non-bonded end) were manually 
removed with forceps under a microscope. Conductive epoxy was applied to each of the 
stud bumped pads and allowed to cure for an hour at 75 oC. Conductive epoxy was then 
placed on the battery footprint pads of the PCBs and the bare dies were flipped, attached, 
and allowed to cure for an hour at 75 oC. Two batteries were then stacked with a process 
similar to the surface mount battery modules.  
To provide the needed current for stimulation, a 1 mF tantalum capacitor was 
mounted on a separate PCB (22 mil) and connected in parallel to the batteries. To provide 
larger values of current, supercapacitors or ultracapacitors may be used as well (Figure 
3.2a). When using a tantalum capacitor, it is important to consider the leakage current. 
Carefully selecting the capacitor and using voltage ratings higher than needed (derating) 
can minimize leakage and also protect against failures due to transient overvoltages.  
Capacitor sizing for the batteries is detailed in Cymbet application note AN-1025. 
Maximum, minimum, and recharge voltages for stimulation were 4.0, 3.0, and 4.1 V, 
respectively. Briefly, the designer must decide the capacitance value and then determine 
if there is sufficient recharge time with the intended power source. Importantly, there is a 
tradeoff between capacitance size and recharge time (Figure 3.2f) that must be considered 
in order to apply a stimulation protocol. This powering strategy should be used in low 
duty cycle applications. For more stringent and power demanding experiments, such as a 
continuous sine wave of stimulation, higher power sources should be used. One possible 




3.5.4 Device Programming 
The microcontroller (MCU) algorithm was created with CrossWorks for ARM 2.2 
(Rowley Associates, Dursley, United Kingdom), a C/C++ development environment. A 
custom development board was designed and fabricated to allow debug and program 
download through a 10-pin serial wire debug (SWD) interface. Current, timing, device 
verification, and power consumption measurements were taken using this development 
board. Example code specific to this device is made available upon request to any 
interested external users for looping stimulation protocols. 
 
3.5.5 Optical Measurements 
Optical power was measured using a triple power supply (Agilent 3631A; Agilent, 
Santa Clara, CA), digital multimeter (DMM, Agilent 34410A), optical power meter 
(PM100D, Thorlabs, Newton, NJ) and sensor (S121C, Thorlabs). The power supply was 
connected in series to the DMM and optical module. A threaded-fiber adaptor (S120-FC, 
Thorlabs) was connected to the S121C sensor to prevent non-fiber emitted light from 
entering. The optical module was stabilized on a stand and the fiber was placed next to 
the sensor through the FC/PC hole. The power meter was set to “Relative Power” to 
subtract the ambient light. For blue light, the wavelength, λ, was set to 473 nm. Optical 
power data points were collected from input currents of 0 – 25 mA. To measure 
frequency and pulse width data, the development board was used with an uncoupled LED. 
The PM100D bandwidth was set to “HI” and the analog voltage output was recorded with 




and only timing information was desired, normalized values were reported. The data was 
normalized by the maximum analog output at a specific current input. 
 
3.5.6 Temperature Measurements 
 Post euthanasia, devices with dental cement intact were removed from the skull 
and 2-wire thermistors were superglued to the ventral surface of the optical module. The 
thermistors were placed adjacent to the optical fiber and the 2-wires were connected to a 
digital multimeter (DMM; Agilent 34410a) with temperature sensing functionality. The 
optical module was controlled with a custom LED driver circuit board, waveform 
generator (Agilent 33522a), triple power supply (Agilent 3631A), and a DMM. The 
DMM was programmed to sample at 1 Hz for 8 minutes while the optical module was 
OFF for 1 minute, ON for 3 minutes, and then OFF for 4 minutes. The input current and 
frequency of stimulation were varied while the pulse width was held at 10 ms. The 
current was varied at 5, 10, and 20 mA while the frequency was 20 Hz. The frequency 
was varied at 10, 20, and 30 Hz when the current was held constant. All measurements 
were taken at room temperature (22 – 24 oC). 
  
3.6 Materials and Methods – in vivo Validation 
For the condition place preference (CPP) experiments, B6.SJL-(CAG 
COP4*H134R/TdTomato);Slc6a3-cre mice (Slc6a3-Cre) were generated by mating 
B6.(ROSA)26Sor<tm27.1(CAG-COP4*H134R/tdTomato)> and B6.SJL-




selectively expressed in dopaminergic neurons. Adult Cre+ and Cre- mice (22-35 g) were 
selected for experimental and control groups, respectively. 
 
3.6.1 Animal Surgery 
Mice were anaesthetized in an induction chamber (5% isoflurane) and then 
prepped for surgery. The mice were secured in a stereotaxic frame (1-2% isoflurane) and 
given carprofen (IP, 5 mg/kg). After the initial incision, connective tissue was removed 
until the skull was exposed. A craniotomy was made above the right ventral tegmental 
area (VTA, AP -3.44, L 0.5). The dura matter was removed and optical fiber was 
implanted to the VTA (AP, -3.44, L 0.5, DV: -4.1) Coordinates were selected from 
previous studies(112) and confirmed with the Paxinos mouse atlas (210). Coordinates 
were adjusted for undersized mice, and a custom stereotactic adaptor was made to hold 
the optical module. After implantation, the optical module was secured with dental 
cement (Liquid Denton, Pentron). Mice were given a SQ bolus of warmed sterile saline 
and allowed to recover for at least 3 full days prior to behavioral testing. The Jackson 
Laboratory IACUC approved all procedures and protocols (#99108).  
 
3.6.2 Conditioned Place Preference 
A randomized 3-chamber CPP procedure was performed over 5 days similarly to 
previously published protocols (42,112,206). Randomization refers to the chamber 
assignment for the unconditioned stimulus (discussed below). Two identical unbiased 
commercial 3-chamber CPP behavioral apparatuses were used (Med Associates, St. 




chambers had a black wall with solid bar flooring and a white wall with mesh grid 
flooring. On the morning of day 1, the pretest was performed. Mice were given 5 minutes 
to habituate in the middle chamber and then 15 minutes to explore. For days 2-4, mice 
were given two 30-minute conditioning sessions, one in the morning and one in the 
afternoon. Conditioning sessions were at least 4 hours apart. For all morning sessions, 
devices were attached but no stimulation was provided. During the afternoon session, 
devices were attached and stimulation (20 Hz for 1 second every 60 seconds, 2-4 ms 
pulse width, 5-10 mA input current) was provided. On the morning of day 5, the posttest 
was performed identical to the pretest. 
After the pretest, a preference score for the black chamber was made for each 
subject. Based on this preference, we randomized the chamber in which each subject 
would always receive optical stimulation (afternoon conditioning session). If any subject 




For fluorescent immunohistochemistry, brains were placed into ice-cold 4% PFA 
for 24 hours followed by 30% sucrose overnight; frozen in OCT compound and 
cryosectioned at a thickness of 20µm. For immunohistochemical staining, the techniques 
outlined in the literature (211)  were followed with a few alterations. Briefly; slide 
mounted sections were allowed to warm to room temperature (RT) in a desiccating 
chamber for 30 minutes and then washed with 5% Triton-X in phosphate buffer (PBST) 




against GFAP, IBA1 or DAT (all Abcam, USA) in 0.5% BSA and 10% chick serum in 
PBST. Sections were then washed 3 times in PBST for 5 minutes each and incubated 
with either chicken or rabbit secondary antibodies conjugated to AF488 (Invitrogen, USA) 
in 0.2% BSA in PBST for 1 hour. Finally sections were washed 3 times for 10 minutes in 
PBST, incubated with DAPI in PBS for 5 minutes, washed again for 5 minutes with 
PBST, mounted in Fluoromount, coverslipped, and sealed with nail polish.   
For cFos staining a Ventana Discovery XT was used with anti-cFos (Abcam, 
Cambridge, MA). The detection kit was a ChromoMap DAB, a multimer-based HRP kit 
(Ventana Medical Systems, Tucson, AZ) using an anti-rabbit secondary (OmniMap anti-
rabbit HRP).   
For Nissl staining and hematoxylin and eosin (H&E) staining, mice were 
euthanized by perfusion fixation with ice cold PBS followed by ice cold 4% PFA, 
embedded in paraffin and serially sectioned to 5µm thick. Sections were deparaffinised 
with two 5 minute washes in xylene and rehydrated through a graded alcohol 
concentration (100%, 95%, 70%). For Nissl staining sections were incubated at 60°C in 
warm filtered cresyl violet solution for 8 minutes. H&E staining sections were incubated 
in hematoxylin for 4 minutes and washed in water for 5 minutes before being blued in 
ammonia water for 1 minute.   Slides were differentiated in two changes of 95% alcohol 
before dehydration in 100% alcohol and cleared with xylene. Slides were mounted with 





3.6.4 Experimental Design 
For CPP, 4 groups were tested: Control 1 (Ctrl 1, n = 4), Control 2 (Ctrl 2, n = 4), 
Treatment 1 (Tx 1, n = 8), and Treatment 2 (Tx 2, n = 6). Optical dose per pulse was 
controlled and determined by multiplying the optical power output by the pulse width 
(PW) as given by: 
 
 . (3.4) 
  
The power output for a given optical module at a specific current input is dependent upon 
the optical efficiency of the LED and coupling efficiency between the fiber-ferrule and 
LED. The optical efficiency of the LED varies with each batch from the manufacturer 
and end users are not provided with information. According to the PointLED data sheet, 
there are four bins of LEDs and the manufacturer does not sort them. Due to this 
uncontrolled factor and variability in fabrication, optical modules will have some 
variance in optical power output for a given current input. This variance accounts for the 
range in optical doses for each group. 
Previous studies have shown ChR2 to be activated in vivo with pulse widths as 
short as 1 ms (38). To demonstrate the capacity of the device to titrate optical doses, we 
first controlled for pulse width (2 ms) and varied the input current for groups Ctrl 1 and 
Tx 1. The input currents proportionally reflected the irradiance per pulse. Either 5 or 10 
mA driving currents were used to deliver the optical doses. There was no behavioral 
difference between groups, and we believed this was a result of insufficient optical dose. 
We then hypothesized a higher optical dose would could result in place preference. For 
€ 




Tx 2 and Ctrl 2, doses were increased by implanting more efficient optical modules and 
ranging pulse widths from 2-4 ms. 
One mouse from Ctrl 1 was excluded from the data analysis due to non-
exploratory behavior during the posttest. The subject’s activity levels were ruled as low 
outliers when grouped with all controls and all mice (Figure 3.7). Another subject 
replaced this control. One mouse participated in both Tx 1 and Tx 2. In Tx 1, this mouse 
had less than a 0.03 change in preference. When participating in Tx 2, this mouse 
performed another pretest and was then conditioned with light on the opposite chamber 
as in Tx 1. Other mice with less than a 0.05 change in preference from Tx 1 were tested 
as well with increasing dose; however, an unexpected disturbance occurred during testing 
and all of those subjects were removed from the study. 
 
3.7 Preference Scoring and Statistical Methods 
After the pretest, the pretest preference for the black chamber was calculated as: 
 
  (3.5) 
  
where,  = preference score and  = time for the respective chambers.  The distribution 
of pretest preferences was plotted in a histogram to determine if the 3-chamber apparatus 
bias existed. Posttest preference scores were calculated similarly: 

















where   = preference score,  = time, and c = black or white. To obtain the change in 
preference, the preference scores from the posttest for the chamber paired to the optical 
stimulation was subtracted from pretest preference score for the same chamber. This is 
given by: 
  (3.7) 
 
To determine if there was a significant difference in ΔP between means from all groups, 
an one-way ANOVA for unbalanced groups was performed. A Tukey-Kramer (α = 0.01 
and 0.05) post-hoc analysis was conducted for multiple comparisons. P < 0.05 was used 
for significance. Pretest and posttest activity scores were compared with a paired 
Students t-test (Figure 3.7). For comparisons between groups, see Figure 3.6 in the main 
text. Statistical analyses were made in MATLAB (R2010a; MathWorks, Natick, MA) and 
STATA 10 (StataCorp, College Station, TX).  
 
3.7.1 Optical Power Analysis 
A least squares linear regression in Microsoft Excel was performed on the raw 
data to predict the optical power output for a given current input. Since input currents 
were typically 5-10 mA, the regression was not forced to cross the y-axis at zero in order 
to minimize bias for lower current data points. Descriptive statistical analysis was 
performed on the slopes and y-intercepts. The mean, 95% confidence intervals and range 










3.7.2 Temperature Analysis 
The ambient temperature, determined by the first minute and last minute of recording, 
was subtracted from the raw data to obtain the change in temperature due to stimulation. 
The maximum value from the 3 minutes of stimulation was selected. Five devices were 
tested and the average maximal change under each set of stimulation parameters was 




CHAPTER 4. THREE AXIS RCFET WIRELESS POWERING CAGE 
Wireless powering of implantable medical devices is a foundational engineering 
challenge in freely behaving animals. Current rodent behavioral studies are dominated by 
wired technologies which are physically restrictive, susceptible to infection from the 
percutaneous connector, and impractical for large scale, chronic experimentation. 
Batteries are popular with clinical devices; however, the weight, size, and lifetime limit 
the applications. Wireless powering technology would obviate the aforementioned 
disadvantages and eliminate the need for batteries. The solution must deliver sufficient 
power to the load while minimizing harmful biological tissue interactions and noise to the 
acquisition system. This work will use the principles of strongly coupled magnetic 
resonance (SCMR) for planted radiofrequency (RF) powering as a solution (136).  
To design a magnetic resonance powering system for biomedical applications 
requires a robust understanding of the relationship between physical design, circuit 
models, and optimization equations. Previously, others have experimentally demonstrated 
powering to multiple receivers (138,146), control of impedance parameters or transmit 
frequency to maximize power transfer with respect to distance (144,212), and powering 
of a left ventricular assist device (LAD) ex vivo (139). Recently, much work has been 
performed using microwave filter design methods, specifically the use of impedance 





such, this work will use microwave bandpass filter (BPF) synthesis techniques to design, 
model, and realize the physical powering solution (144,146,213-215). In particular, the 
resonantly coupled filter energy transfer (RCFET) method developed by Mei et al. is used 
to design the WPT system (147). Section 4.1 will introduce basic concepts important to 
BPF WPT systems. Section 4.2 will detail basic BPF design equations. Section 4.3 
arrives at an impedance match condition with respect to the characteristic impedance of 
K-inverters. While the impedance match condition is not novel, to the author’s 
knowledge, the specific equation has not been shown in literature. Section 4.4 discusses 
the RCFET method and validates the design solution against the impedance match 
equation in Section 4.3. The RCFET method should arrive at the same impedance match 
solution for maximal WPT. Detailed RCFET equations will not be presented as the work 
is currently unpublished and is the intellectual contribution of Mei et al. (147). Section 
4.5 presents the novel design of the three-axis RCFET wireless powering cage and 
preliminary in vivo results. Future work will be to more extensively validate the cage in 
vivo. Novel contributions in this chapter are as follows: 
1) Derivation of the optimal impedance match condition with respect to 
the characteristic impedance of impedance inverters (K-inverters) 
2) Design of the three-axis RCFET wireless powering cage 









4.1 Basic Concepts in Bandpass Filter Wireless Power Transfer Design 
4.1.1 Description of Resonantly Coupled Systems 
The first demonstration of magnetic resonance coupling used 4 coils—2 loops and 
2 resonators (Figure 4.1) (136). The first loop is connected to the powering source and 
inductively coupled to one resonator. In a mirroring fashion, the second loop is connected 
to the load and inductively coupled to the other resonator. The two resonators are 
resonantly coupled.  
 
Figure 4.1 Four coil strong magnetic resonance powering configuration. Mi,j = mutual 
inductance between coils i and j. ki,j = coupling coefficient between coils i and j.  Cross 
coupling between L0 and L2, L0 and L3, and L1 and L3 are 0 and not shown in the figure. 
Z1 = the impedance seen by the source. 
 
The electromagnetic energy exchange between two coils (i and j) is described by the 
coupling coefficient, ki,j (142).  Coupling is primarily a function of geometry and physical 
positioning of the powering coils (216). For instance, as two axially aligned coils are 
separated farther apart or misaligned, the coupling coefficient decreases. The other 
crucial physical parameter in inductive and magnetic resonant systems is the quality 
factor, Q, of the coils. The quality factor is the ratio of the energy stored to energy 
dissipated. In coils, Q can be related to the inductance, L, and series resistance, R, at the 







Q ≈ w0LR  (4.1) 
Q and k are the two most import physical factors in maximizing power transfer and are 
often described as the multiplied entity, kQ (217,218). As k is defined by the physical 
powering setup, much research has been placed on coil design to maximize Q (218,219). 
Low kQ systems will limit the maximal power transfer efficiency. 
In Figure 4.1, the coupling coefficients k0,1 and k2,3, are known as external 
coupling coefficients. These terms describe the relationship between a load or individual 
input and output ports with the nearby internal resonator. Mi,j represents the mutual 
inductance between coils i and j and describes the rate of magnetic flux change in coil j 
with respect to the rate of current change in coil i.  Similar to the coupling coefficient, the 
mutual inductance is only dependent on the geometry of the coils. The relationship 
between ki,j and Mi,j is (213): 
 (4.2) 
 
The mutual inductance between coils directly affects the impedance parameters of the 
circuit. The impedance seen by coil 1 due to coil 2 is equal to (212): 
  (4.3) 
where i = (-1)1/2 and ω is the angular frequency. 
Maximum power transfer between a source and load is observed when the source and 
load impedances are equal (purely resistive) or conjugately matched (reactive 











currents in each unique branch of the circuit (136,212,220). This results in a set of 
lengthy and complex equations as the number of coils increases. To physically realize the 
model, the coupling coefficient, k1,2, between the two resonators can be determined first 
by measuring the mutual inductance for a specific distance and orientation. Then the 
external coupling coefficients can be tuned to meet the impedance condition. Tuning is 
achieved by rotating or increasing the distance of L0 with respect to L1 or L3 with 
respect to L2 (136,143). Defining the optimal impedance condition, desired coupling 
coefficient between resonators, and tuning external coupling coefficients are the critical 
steps in designing WPT systems for maximum power transfer. 
 
4.1.2 Maximal Power Transfer with BPF Design Methods 
BPF synthesis is a well-developed field that has been traditionally used for 
telecommunications (214,220). Using BPF for WPT is different to telecommunications in 
two respects (146). Firstly, in WPT system for biomedical applications, the physical 
system is defined by the end experiment. Then the optimal filter parameters are solved 
for. In telecommunications, the desired filter parameters are defined first and then the 
physical solution is realized. Secondly, all the traditional BPF parameters are not critical 
for optimal performance in WPT. The filter response should be maximally flat; simple 
Butterworth filters are typically used.  The physical power transfer system of Kurs et al. 
(136) can be viewed as a BPF model (215) (Figure 4.2). This equivalent circuit has 3 
primary advantages: 1) a direct-coupled resonator is realized which results in the use of 





implemented on miniature circuit boards, and 3) the optimization of power transfer is 
greatly simplified. 
 
Figure 4.2 Bandpass filter representation of the four coil physical model in Figure 4.1. 
The coupling coefficients between coils can be modeled as impedance inverters, Ki,i+1. 
The external K-inverters are tunable (blue) while the impedance inverter, K1,2, is defined 
by the geometric structure of L1, L2 and the distance between them. ZL is the load 
impedance. Z1 is the impedance looking into K-inverter K2,3. Z2 is the impedance looking 
into K1,2, and Z1 is the impedance looking into K0,1. C1 and C2 are capacitor values 
forming resonators with L1 and L2, respectively. Coils are assumed to be of low loss. If 
coils have high loss, a series resistance should be inserted at each coil. Rs is the source 
resistance and Vs is the AC voltage source. 
 
The mutual inductance between coils can be transformed or represented by 
immittance (impedance, K, and admittance, J) inverters (142,213).  The immitance 
inverters invert the impedance or admittance seen by the port of analysis (Equation 4.4, 
Figure 4.3).  Previously, both K and J inverters have been used in BPF design of wireless 
powering (142-145). K and J inverters are reciprocally related and are more convenient 
when dealing with series and parallel resonators, respectively (213). In this work, K 
inverters will be used. Ki,i+1 denotes the characteristic impedance of the K-inverter 
between coil i and coil i + 1. For external couplings, the K-inverter represents the 








Figure 4.3 K-inverter impedance inversion. Ki,i+1 can be viewed as a two port network. 






ZL  (4.4) 
Maximal power transfer is achieved when the BPF has the lowest insertion loss. This 
occurs when the proper impedance match condition between the source and load is 
reached. BPF WPT design methodologies attempt to arrive at either the proper 
impedance matching conditions (144-146) or minimizing insertion loss (147). Typical 
behaviors of a resonantly coupled power transfer system are shown in Figure 4.4. Three 
distinct power transfer regions are observed with two coupled resonators: over-coupled, 
critically coupled, and under-coupled (Figure 4.4a). Over-coupling provides good power 
transfer but splitting of the resonant frequency occurs (136,212). The frequency split 
widens as the coupling coefficient nears 1. Power transfer is now optimal at two different 
frequencies for a particular coupling coefficient, and power transfer at the resonant 
frequency is suboptimal. The critically coupled point provides maximal power transfer 
without frequency splitting, and the under-coupled region provides lower power transfer. 







Figure 4.4 Power transfer behavior of two coupled resonators. The dotted line indicates 
where the critical coupling point. This is where maximum power transfer is achieved at a 
single frequency. k12 is the coupling coefficient. PTE = power transfer efficiency. *** = 
undercoupled region and is typically where biomedical devices operate. 
 
Most previous WPT systems have performed in the critical to strongly coupled regions 
due to the high power transfer efficiencies (136,212,215). This cannot always be realized, 
however. The general behavior of Figure 4.4 should be observed with any two-resonator 
power transfer system given that the Q’s are infinite. In implantable biomedical systems, 
though, Q’s are typically low due to the size of the receive coil. For instance, Harrison 
used receive coils with a Q less than 10 (131), and Jow et al. have designed planar spiral 
coils with Q’s less than 90 (219). As Q decreases, the maximal achievable optimal PTE 
also decreases. Interestingly, at some low Q threshold, a given power transfer system no 
longer exhibits the critical or over coupling behavior seen in Figure 4.4 (147). This is the 
case for implantable biomedical systems as Q’s of small coils are far from ideal. As in 
traditional inductive powering topologies, wireless power transfer design is thus limited 
to the undercoupled region. Traditional inductive coupling techniques, though, load the 





inverters do not load the resonant coils and creates the proper impedance match to 
achieve higher PTE’s. The WPT system in this chapter is designed to operate in the 
undercoupled region but is able to maintain sufficient power transfer due to optimized 
impedance matching. 
 
4.2 Design Equations 
Filter synthesis theory begins with a low pass prototype model that is transformed 
to the desired filter type (213,214,220). A maximally flat, Butterworth filter response is 
used throughout this work. From the prototypical element values of the desired filter 
response, the relationship between mutual inductance and the characteristic impedance 
can be found. Equations 4.5-11 show the relationships for the BPF in Figure 4.2 (213). 
  (4.5)
 
  (4.6) 
  (4.7) 
  (4.8) 
  (4.9) 
  (4.10) 
  (4.11) 
where FBW = fractional bandwidth, f0 = resonant frequency, w0 = resonant angular 
frequency. The element values are specific to the maximally flat filter response and 






K0,1 = M0,1 RsL1w0FBW
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and 4.6-8, the relationship between coupling coefficient and the characteristic impedance 
of K-inverters can be easily determined. K-inverters can be physically realized by several 
circuit topologies and many options can be found in Matthieu et al (213). In this work, a 
2 capacitor network is used to represent the external couplings (Figure 4.5). 
 
Figure 4.5 The physical realization of the external K-inverters, K0,1 and K2,3. Cs and Cp 
are series and parallel capacitors, respectively. ZL is the load impedance and Zin is the 




Figure 4.6 Physical implementation of the bandpass filter. The external coils are replaced 
by K0,1 and K2,3. K1,2, is defined by the geometrical properties of L1 and L2. C1 and C2 
form a resonant structure with L1 and L2, respectively. C1 and C2 can be absorbed by Cs1 
and Cs2, respectively, to reduce components. ZL is the load impedance. Rs is the source 
resistance. Vs is the AC source voltage. Compare to Figure 4.1 and Figure 4.2. 
 
The resulting physical manifestation of the BPF is shown in Figure 4.6. Assuming ZL is 
purely resistive, the relationship between the capacitors and the characteristic impedances 














The values of C1 and C2 are determined by the desired resonant frequency, f0 (equations 






From the previous equations, the physical realization of K-inverters allows the direct 
tuning of the external coupling coefficients by 2 capacitor values. Additionally, it 
removes the need for inductors L0 and L3 (Figure 4.1 versus Figure 4.6). Deriving the 






























4.3 K-inverter Impedance Match Condition for a 2 Resonator BPF 
The impedance matching condition of resistive loads for maximum power transfer 
occurs when Z1 = Rs. Previously, Lee et al., demonstrated this condition for J-inverters 
(144). A similar analysis can be applied to K-inverters. For a 2 resonator BPF (Figure 
4.2), the impedance matching condition for the BPF is determined in Equations 4.18-4.23. 











Assuming a 50 ohm source and load, the matching condition is Equation 4.23. 
  (4.23) 
 
The process to design a BPF wireless powering system using the impedance match 
condition is as follows. First, M1,2, L1, and L2 are measured with a vector network 
analyzer at the resonant frequency. K1,2 can then be determined. K0,1 and K2,3 are 































Equations 4.12-4.15. For low Q power transfer systems, the series resistance of each coil 
would need to be added to the circuit model and equations. The high Q impedance match 
condition (Equation 4.23) is used in Section 4.4 to validate the RCFET design 
methodology. 
 
4.4 RCFET Methodology 
The RCFET design methodology developed by Mei et al. optimizes the BPF for 
minimal insertion loss (147). The design method is unique in 2 respects: 1) the method 
arrives at the minimal insertion loss criteria using the measured coil properties of 
inductance, quality factor, and mutual inductance, and 2) K-inverter realization of the 
capacitor values is not arbitrary. Previous methods in BPF synthesis optimize by only 
measuring L and k and then arbitrarily choosing characteristic impedances to arrive at the 
impedance match condition (144,146,215). As k and Q are both critical factors in PTE, 
this difference allows the designer to predict the power seen by the load in simulation and 
also realize realistic capacitor values for the K-inverters without several design iterations. 
The RCFET design method is as follows: 1) measure coil properties and coupling 
coefficient range between coils, 2) define a targeted critical coupling point to optimize for, 
3) calculate the optimal mutual inductances 4) calculate the characteristic impedances 
and 5) determine the K-inverter capacitor values. A comparison to previous design 






Figure 4.7 Design process of BPF wireless powering systems. The left flow chart 
calculates capacitor values by arbitrarily choosing characteristic impedance values for 
K0,1 and K2,3 to satisfy equation 4.23. The RCFET design method is shown on the right 
column. 
 
As the design equations of the RCFET are unpublished, they will not be provided here. 
Instead, simulations and physical measurements are used to validate against the derived 
K-inverter impedance match condition. To demonstrate the RCFET methodology, a 2 
resonator BPF design example is shown. Measured quantities including L1, L2, Q1, and Q2 
can be found in Table 4.1. Figure 4.8 displays how the coupling coefficient changes with 
respect to distance for coils L1 and L2. The target critical coupling point critical is chosen 
to be equal to 0.03. To validate the RCFET derived capacitor values, the impedance 
match condition from Equation 4.23 is first verified and the values are reported in Table 
4.1. The values are in good agreement.  The slight mismatch is due to finite Q, which is 
not accounted for in Equation 4.23. RCFET, however, does account for coil losses. k1,2 is 





(Figure 4.9). Simulation (dotted black trace, Figure 4.9) and measurement (blue trace) are 
in good agreement thereby validating the RCFET methodology. 
Table 4.1 Two Resonator BPF Design Example 
RCFET Input values Calculated values 
L
1
 805.7 nH K0,1 9.0401 
L
2
 805.8 nH K1,2 0.8096 
Q
1
 383.5 K2,3 4.5159 
Q
2
 95.71 Cs1 || C1 2.438 nF 
f
0
 3.998 MHz Cp1 10.111 nF 
FBW 0.04 Cs2 || C2 3.188 nF 
Rs 50 Ω Cp2 5.007 nF 
ZL 50 Ω K1,2 x 50 30.3608 
  K0,1 x K2,3 30.8175 
 
 
Figure 4.8 Coupling coefficient, k1,2, for two resonator BPF design example. k1,2 
decreases as the distance increases between coils L1 and L2. Coil parameters are found in 
Table 4.1. 
 


















Figure 4.9 Simulation and measurement of the PTE with respect to frequency. Power 
transfer is nearly 0 dB at the critical coupling point. Refer to Table 4.1 for component 
properties of the RCFET design example.  
 
4.5 Three-axis RCFET powering cage 
Wireless technology for freely behaving animal experiments require powering in 
three spatial axes. The two resonator powering strategy is sufficient for experiments 
where the subject is stationary (i.e. a virtual reality jet ball). Chronic, epilepsy related 
experiments, though, need spatial freedom to study seizures and behavior. The 
engineering objective is to design a powering system that would allow unrestricted rodent 
housing and continuous powering. The proposed solution is a three-axis RCFET cage 
(Figure 4.10). Coil 1 is the transmit coil and has magnetic, B, fields in the Z-axis. Coils 
2a and 2b are relay coils with B fields in the X axis and Y axis, respectively.  
 





















Figure 4.10. Three-axis RCFET wireless powering cage. Direction of magnetic fields, B, 
produces are shown on the right. The cage dimensions are 12” x 12” x 11.5” (L x W x H). 
The coils are made of 8 gauge copper wire. The top center wires are removable to 
provide access for the subject. The receive coil is circular and 20 mm in diameter (not 
pictured). 
 
The cage design method is to 1) define acceptable coil sizes 2) sweep coil parameters for 
high Q with respect to frequency 3) measure coil to coil coupling 4) determine optimal 
capacitor values using RCFET and 4) verify simulations with measurements. This is 
similar to the method in Figure 4.7. The cage is first characterized assuming a 50 ohm 
source and 50 ohm load. This allows s-parameter measurements with the vector network 
analyzer. Once the correct impedance matching conditions have been established, the 
features of the power transfer frequency response are recreated for a complex, non-50 
ohm load. In the case of powering a device, the load is a rectifier (AC to DC converter) 






According the NIH Guide for the Care and Use of Laboratory Animals, group 
housing rats weighing 400-500 g require 60 in2/rat of floor space and 7 inches of height 
(221). Often rats induced with seizures are singly housed and would require more floor 
space. To allow ample of space, the powering system is designed to fit a separate 11 x 11 
x 11 in3 housing unit. The powering system is built with a polycarbonate box. The 
primary external source coil, coil 1, wraps around the box first. Then two other external 
coils, coil 2a and 2b, are wrapped perpendicularly to coil 1 (Figure 4.10). Coil 2a and 2b 
weakly couple to coil 1 and serve as relay coils to reorient the magnetic fields. Coils 1 – 
2b are nearly the same size and have similar Q factor and inductance values (Table 4.2). 
The Q is slightly lower for both coil 2a and 2b since both coils contain detachable wires 
to allow entrance of the animal. The receive coil is small compared to the wrapped coils. 
The diameter is 20 mm, and this size is tolerable by adult (260 g or larger) rats. 
Decreasing the implantable coil size is an optimization that should be considered for 
future iterations of the powering system.  
Table 4.2 Coil Parameters for a Three-Axis RCFET Wireless Powering Cage 








Measured Q  
@ 4 MHz 
323.8 262.5 270.1 85 
Inductance L, nH  
@ 4 MHz 
4252 4400 4325 346.9 















4.5.1 Magnetic Field Interactions 
The three external coils allow energy to couple the receive coil in all orientations. 
There are 2 general powering strategies to couple energy to the receive coil: 1) use each 
external coil as an independent source coil 2) use one external coil as the source and the 
other 2 coils as relays. Option 1 more simply realizes continuous powering through 
theory as the case is simply 3 independent, 2 resonator BPF’s. Practical realization is 
costly and disadvantageous, though. Multiple signal generators, phase shifters, and power 
amplifiers would be required. Option 2 is theoretically more challenging, but 
implementation requires only a single signal generator and power amplifier. Power is 
transferred either directly from coil 1 to coil 3 or indirectly from coil 1 to relay (coil 2a, 
coil2b) to coil 3. Option 2 is used due to cost and end user accessibility. 
The interaction of magnetic fields from the drive coil and relay coils to the receive 
coil must be considered for powering in various orientations. This conceptualization and 
result is critical, as extensive coupling coefficient measurements would otherwise be 
required with each cage iteration to observe the behavior. Current through coils 1, 2a, and 
2b create alternating magnetic fields with component vectors in the Z, X and Y directions, 
respectively. According to Faraday’s Law, the magnetic field from coil 1 induces an 
electromotive force (emf) that is seen by both coils 2a and 2b. The emf pushes a current 
through the relay coils, which then create magnetic fields. The emf is 90o out of phase 
with respect to the coil 1 magnetic field (Figure 4.11). At resonance, the impedance is 
real, and the induced current within the relay coils is in phase with the emf. Given these 
conditions, the coil 2a magnetic field is always in phase with the coil 2b magnetic field. 





coils are coupling energy, using vector addition, the total magnetic field will oscillate in 
amplitude in a singular direction throughout the entire XY plane (Figure 4.12). When the 
receive coil is perpendicular to the total magnetic field vector, then the most amount of 
power will be received as the induced currents due to the component magnetic vectors are 
in the same direction and sum. When the receive coil is parallel to the total magnetic field 
vector, then the least amount of power will be received. The induced currents due to the 
magnetic vectors are in opposite directions and cancel. In this particular case, the receive 
coil will see either maximal or no power at 45o (225o) and 135o (315o) with respect to 
either relay coil. Coils 2a and 2b couple energy equally into the receive coil at these 
orientations. Adding a Z component to the total vector does not influence the power 
transfer when the receive coil is perpendicular to coil 1.  To avoid the dead orientations 
(no power transfer), coils 2a and 2b cannot be simultaneously coupling energy.  
 
Figure 4.11 Phase of induced emf of relay coils 2a and 2b at resonance (4 MHz). The 
magnetic flux, B, due to coil 1 induces an emf in coils 2a and 2b. When the slope of B is 
0 (peaks and troughs), then the induced emf goes to 0. The resulting current in the relay 
coils is in phase with the induced emf. The magnetic flux from coils 2a and 2b are then in 







Figure 4.12 Power transfer when two external powering coils have in phase magnetic 
fluxes. The receive coil (red) is shown in various orientations in one plane. B1 and B2 
represent the magnetic flux orientation of two coils. The flux magnitude will follow the 
sinusoidal pattern shown in Figure 4.11 (blue trace). B total is the sum of B1 and B2. The 
direction of B total will become negative when B1 and B2 are both negative. Power is 
maintained except in the second orientation from the left. The B1 and B2 components 
will induce currents in opposite directions at the same time within the receive coil If the 
currents are equal in magnitude, no power will be received. If there is a 90O phase 
difference between B1 and B2, the currents in orientation 2 will still be opposite; 
however, the time difference between the induced currents prevents cancellation.  
 
The case of power transfer due to interactions between coil 1 and one relay coil (2a or 2b) 
is more complex. The case will be considered for interactions between coil 1 and coil 2a. 
The coil 1-coil 2b case should be nearly equal. The magnetic field between coil 1 and coil 
2a is 90o out of phase since at resonance. The induced emf seen by coil 2a and resulting 
current are in phase. The total magnetic field vector over one period of oscillation 
generates vectors in every direction of the XZ plane. This should result in no power 
transfer dead orientations when the receive coil is perpendicular to the plane. Some 





from coil 1 is greater than coil 2a. The coil 1-coil 2b case is similar but with field 
components in the YZ plane. 
The results from the magnetic field interactions analysis provide the following 
physical guidelines for the cage design: 1) coil 1 and a relay coil can provide power 
transfer to a receive coil in all orientations perpendicular to the powering plane, and 2) 
coils 2a and 2b cannot concurrently act as relays. The design solution is realized with 
optical solid-state relays to switch the relay coils on and off (Table 4.3).  When coil 2a is 
acting as a relay, the terminals of coil 2b are shorted. When coil 2b is acting as a relay, 
the terminals of coil 2a are shorted.  This solution sets the physical conditions of cage. 
The power transfer system can be modeled as a three resonator BPF with two operating 
conditions. 
Table 4.3 Operation of the Transmit and Relay Coils 
 Time Point 1 Time point 2 
Coil 1 (Tx) ON ON 
Coil 2a (Relay) ON OFF 
Coil 2b (Relay) OFF ON 
 
4.5.2 Three Resonator BPF and Impedance Match Condition 
When compared to the 2 resonator BPF, the three resonator BPF model introduces 
two K-inverter terms. Figure 4.13 is the model for a 3 resonator BPF. L1 is the 
transmitting coil; L2n is the nth relay coil; L3 is the receive coil; Rs is the source resistance 
(50 Ω); ZL is the load impedance; Z1-4, are the input impedances seen by the respective 







Figure 4.13 Three resonator BPF model of the three-axis powering cage. Orange K-
inverters are set by the geometric relations of the coils L1, L2n, and L3. The blue K-
inverters are tuned using a two capacitor topology. L1 is the transmit coil, L2n is relay coil 
2a or 2b, L3 is the 20 mm diameter receive coil. ZL is the load impedance and Zi is the 
input impedance of the Ki,i+1 inverter. Vs is the AC voltage source.  
 
If it is assumed that the components are lossless, the source and load are real, and no 
coupling exists between coil 1 and the receive coil, then the coupling coefficient between 
coil 1 and 3 and K1,3 are 0. Under this condition, deriving the optimal impedance match 
condition with respect to K-inverters is straightforward and follows the process from 
Equations 4.18 – 4.23. When Z1 = Rs, then the relationship between characteristic 




K1,2K3,4 = K0,1K2,3  (4.24) 
 
When cross coupling between resonators (i.e. k1,3) cannot be ignored, then the impedance 
match condition can be solved by using the impedance matrix. Lee et al., previously 





model with relay coils (145). As J inverters are reciprocal to K-inverters, this condition is 








2R  (4.25) 
 
where [Z] is the impedance matrix of the BPF, and R is the impedance value of the 
source, Rs, and load, ZL, (assumed to be equal). The impedance matrix terminology for a 
BPF can be found in standard microwave filter-engineering textbooks (213,214). Using 
Matlab, the 
€ 





K1,2n (K1,2nK3,42 − 2K1,3K2n,3Rj)
R(K0,12 K2n,32 +K1,2n2 K3,42 − 2K1,3RK1,2nK2n,3 j)  (4.26)
 
 
To verify that the RCFET method and this impedance match condition can arrive at the 
same solution for a 3 coil BPF, a simulation is run with arbitrary coil parameters and 
coupling coefficients (Table 4.3). High Q components are assumed, and the source and 
load are 50 ohms. The impedance match condition sets 
€ 
[Z]1,1−1= 0.01. From Equation 4.26, 
the RCFET method arrives at 
€ 
[Z]1,1−1  = 0.0108 + i00261. These values are in good 
agreement. The advantage of the RCFET method becomes obvious as the number of 
resonators used in a BPF increases. Arbitrarily sweeping parameters to find usable 
characteristic impedances for K0,1 and K3,4 to satisfy the impedance matrix derived 





condition can be determined for low Q coils used implantable biomedical applications, 
the equations quickly complicate with increasing number of coils. 
Table 4.4 Three resonator BPF design example 
RCFET Input values Calculated values 
L1 6465 nH K0,1 6.49e5 
L2 4098 nH K1,2 3.32e8 
L3 400 nH K2,3 2.75e7 
Q1 10000 K3,4 5.41e4 
Q2 10000 K1,3 2.02e8 
Q3 10000 1/2R 0.01 
f0 4.0 MHz 
€ 
[Z]1,1−1  0.0108-0.0026i 
FBW 0.043   
Rs 50 Ω   
ZL 50 Ω   
    
 
5.5.3 Coupling Coefficient Factors and Measurements 
Defining the critical coupling coefficient to be used in the RCFET method 
requires knowing the range of coupling coefficients between the receive coil and the 
source or relay coil. Additionally, the general trends of coupling are important for design. 
The coupling coefficient can change with respect to receive coil location and orientation. 
To map the coupling coefficient trends with respect to location in the cage, the mutual 
inductances at various locations within coil 1 are measured with a 2-port setup in with the 
VNA (Figure 4.14). This method provides a faster technique to understand the general 
trend of coupling, but the measurements are less accurate than a 1-port measurement 
(213,214). These measurements are lower than the true coupling coefficient since the low 
Q receive coil is further loaded. After understanding the general trends, a more accurate 





measurements. Coil 1 and the receive coil were aligned in a parallel fashion. The XZ 
plane coupling map shows a saw tooth pattern for coupling. The greatest coupling occurs 
near the coil wrappings and the smallest coupling is half way between two consecutive 
coil turns (Figure 4.14a). The YZ plane has the same trend. The XY plane coupling map 
shows that the coupling is greater on the ends and dips toward the middle (Figure 4.14b). 
As the XY plane is moved along the Z axis, the same trend is observed. At Z = 6.5 cm 
and 13.5 cm, though, instead of dipping towards the center, the coupling increases. This 
shows that the worst coupling points are at the corners for 6.5 and 19.5 cm along the Z 
axis. Away from the external coil edges, the coupling in the majority of the space is 
homogeneous. As the receive coil orientation is rotated from parallel to perpendicular 
with respect to coil 1, the coupling coefficient decreases and drops to 0 at 90o. These 
general trends hold when the receive coil couples to any coil, source or relay.  
Understanding the general trends in coupling, the locations with the maximum and 
minimum coupling are measured with a 1-port technique. Simulation in ADS is then used 
to establish a more accurate coupling coefficient range (147). The range of k1,3 is 0.0049 
to 0.0064.  
The optimal power transfer condition is different for every unique coupling 
coefficient. For a first generation technology, the goal of the powering system is to 
provide sufficient powering and not always optimal powering under every condition. The 
power required by a device described in chapter 2 is typically < 4 mW. Assuming a 60% 
rectifier efficiency, 6.67 mW of power delivered to the load is the targeted specification. 





power transfer efficiency specification at a singular frequency for all coupling 






Figure 4.14 Coupling trends throughout the three axis cage. k13 is the coupling 
coefficient between the transmit and receive coils. a) Coupling in the XZ plane at Y = 0 
cm. The receive coil is moved along the dotted lines in the Z direction. Colors of the 
dotted line in the schematic correspond to the colors in the plot. Coupling is greatest near 
the coil wrappings (0, 13, 26 cm). The coupling dips between the wrappings (6.5, 19.5 
cm). These dips are the weakest coupling points when the receive coil is parallel to the 
transmit coil. The same trend is observed in the YZ plane. b) Coupling in the XY plane at 
Z = 26 cm. The receive coil is moved along the dotted lines in the X direction. The 
greatest coupling occurs at the ends (0 and 26 cm). The coupling dips toward the middle. 
The same trend is observed while moving the XY plane along the Z-axis.  c) Coupling as 
a function of angle. As the receive coil is turned from parallel to perpendicular, the 
coupling drops. At 90o, the coupling is negligible. 
 
The parameters used for optimization are shown in Table 4.5. The targeted critical 
coupling point between the receive and transmit coil is 0.005, which is near the coupling 
coefficient of most cage areas away from the edges.  The implemented capacitor values 
were verified by measurement on the VNA.  
 
Table 4.5 3-Axis RCFET Wireless Powering Cage Optimization Parameters  
RCFET Input values Calculated values 
L1 4252 nH Cs1 399.12 pF 
L2a 4400 nH Cp1 5430.31 pF 
L2b 4325 nH Cs2 6303.30 pF 
L3 346.9 nH Cp2 16497.64 pF 
Q1 323.8   
Q2a 262.5   
Q2b 270.1   
Q3 85 Implemented values measured 
by VNA @ 4 MHz 
f0 4.0 MHz Cs1 399.6 pF 
FBW 0.043 Cp1 5.413 nF 
Rs 50 Ω Cs2 6.272 nF 
ZL 50 Ω Cp2 16.972 nF 
k12a 0.0047   
k13 (target) 0.005   






The physical realization of the cage is shown in Figure 4.15. Receive coils and power 
measurement systems for a 50 Ω load and complex load are pictured in Figure 4.15c. The 
coil on the left of is matched for a 50 Ω load. The devices in the middle and on the right 
of Figure 4.15c are wireless power measurement boards used when transitioning to a non-
50 Ω.  Using a 2-port setup on the VNA, the power transfer measurements are made by 
connecting the K0,1 input to port 1 and K3,4 output to port 2. The power transfer 
simulation and measurements for a 50 Ω load are shown in Figure 4.16. 
 
Figure 4.15 The three axis RCFET powering system. a) side angled view of cage. The 
external K inverter, K01, is boxed in blue. Three perpendicular coils are seen. Each side of 
the bottom of the cage is 12 inches. The height is 11.5 inches. b) Side view of cage. The 
arrow points to coil 1. Coil 2 wraps vertically and perpendicular to coil 1.  c) Receive 
coils and powering boards. Coil 3, the receive coil, is shown by the red arrows. K3,4 for a 
50 ohm load is boxed in blue. The devices on the left are unpackaged (middle) and 
packaged (right) versions of the wireless power measurement system. The AC voltage is 
rectified to DC and then measured with a MCU. The data is then wirelessly transmitted to 
a basestation. Sampling occurs at 2.5 kHz.  The black bar is 5 mm. 
 
Figure 4.16 displays power transfer in terms of S21. Measurements at a strong and weak 
coupling points corresponding to the general trends in Figure 4.14 are made. Additionally, 
a measurement is taken at the middle of the cage. All measurements are taken with the 







Figure 4.16 Two port measurements of the powering cage for a 50 Ω load. All 
measurements are taken with the receive coil parallel to the relay or transmit coil. a) 
Measurement taken with coupling at a maximum to the transmit coil (corner location, see 
Figure 5.14).  Dotted line is the simulation case and red line is the measurement. b) Same 
as (a), but coupled to the relay coil. c) Measurement comparisons of the a strong coupling 
position (red), the middle of the cage (blue) and a weak coupling position (black) when 
coupled to the transmit coil.  d) Same as (c), but coupled to the relay coil. 
 
Figure 4.16a and Figure 4.16b show simulation (dotted black trace) S21 response and the 
measured S21 response (solid red trace) for the receive coil coupling to the transmit and 
relay coils, respectively. These measurements were made at the optimal coupling location 





measured frequencies, but at 4 MHz, there is a negligible difference. In Figure 4.16c and 
Figure 4.16d, the coupling at a strong coupling location (red trace), the center of the cage 
(blue), and a weak coupling location (black trace) are shown for the receive coil coupling 
to the transmit a relay coil respectively. The maximum PTE of the measurements for a 50 
Ω load range from 2.3 to 7%. 
 
4.5.3 Preliminary in vivo Validation 
Validating the cage with a device requires retuning the system for a complex load.  
A power management circuit is used to convert AC to DC, store energy, and regulate 
supply voltages (Figure 4.15c). A two-stage rectifier topology is used to perform AC to 
DC conversion and a low noise linear dropout regulator provides a 1.8 V supply voltage. 
The setup is similar to Figure 2.25, but there is only one device and an additional 700 Ω 
load at the regulator output. From previous design experience with a 1-axis cage and 
ADS simulation, the rectifier board impedance is known to be 0.78 + j106.9 Ω. Using 
RCFET simulations for the known rectifier load, the characteristic impedances K-inverter 
capacitor values are determined and mounted onto the power measurement boards. With 
a 500 mW input at 4.01 MHz, rectified voltage values range from 1.79- 3.32 V. 
Assuming 50% rectifier efficiency, this translates into a PTE range of 1.8-6.28% which is 
in good agreement with the 50 Ω load case. 
 Preliminary in vivo validation is performed in two similar cages and brief 
recording sessions. Future work will be to pursue validation with longer time periods. 
The packaged device in Figure 4.15c is implanted subcutaneously in the flank of a rat, 





open-loop configuration and constantly toggled at 200 Hz (Table 4.3). The rectified 
voltage is reported and shown in Figure 4.17. The rat is visually observed and time points 
where the rat is moving or is stationary are indicated in red and blue, respectively. As the 
rat moves, it can be seen that the voltage fluctuates. Critically, the rectified voltage is 
maintained above the regulator voltage of 1.8V. When the animal is stationary, the 
rectified voltage can be seen to stable. At the beginning and end of the recording session 
shown, the animal is in different locations of the cage explaining the difference in 
rectified voltage.  
 
Figure 4.17 Wireless powering in an animal using the three axis RCFET cage. Rectified 
voltage at the input of the regulator is shown and continuously stays above 1.8 V 
(regulator voltage). Rectified voltage fluctuates more while the animal is moving than 
when it is stationary. Power output is 630 mW at 4.11 MHz. 
 
The second data set uses the same device configuration as Figure 2.25. One rectifier 
board supplies power to two devices for 4 channels of biopotential acquisition. In this 





control algorithm is implemented into the basestation. The basestation both receives data 
from the devices and toggles the relay coils. The basestation uses a timer that looks for 
data packets received. If a data packet is not received for 200 ms, indicating a lack of 
power, then the switching function is initiated. This is preferable to the open-loop case 
since the open loop switching frequency is in input range of acquisition devices. Noise 
from switching will be introduced and amplified. More complex control algorithms can 
be designed for smoother voltage regulation and less packet loss. The recording session is 
for 4.5 minutes, and the data of interest is the number of data points received. 673770 
data points are expected in this time frame and 636940 data points were received 
indicating a 94.53% of successful data transmission. Additionally, the data suggests that 
the implanted devices did not restart and the lost packets were due to dropped packets 
and not powering. This data shows the three-axis RCFET powering cage can reliably 
deliver power to multiple devices with less than 1 W output power. Further in vivo 
validation with biopotential measurements is required.  
 
4.6 Conclusion 
The design methodology and bench top characterization of a three-axis RCFET cage 
is presented. For a 20 mm diameter receive coil, PTE from 1.8 – 6.28% are achieved. The 
powering volume is 11 in x 11 in x 11 in and is large enough to house adult rats. 
Preliminary in vivo results are shown, but further chronic work is needed to establish the 






CHAPTER 5. CONCLUSION 
Implantable medical devices are becoming more prominent, and DBS is entering an era 
of tremendous clinical investigation. Optimization of DBS to control diseases and 
disorders such as epilepsy, SUDEP, and urinary incontinence will require much 
laboratory research. Miniature wireless devices are thus poised to greatly enable 
neuroscience researchers. This dissertation presented a platform of wireless technologies 
that can be used for biopotential acquisition, electrical stimulation, optical stimulation in 
optogenetics, and freely behaving wireless powering. To the author’s knowledge, Chapter 
2 presents the first implantable, miniature closed-loop device for use in chronic epilepsy 
experiments. Measuring 7 x 14 x 3mm and weighing less than 0.7 g, it is a uniquely small 
COTS device that can be easily integrated with a wireless powering system and remain 
implantable. The core recording and stimulating technologies were validated in vivo, and 
it was shown that the device could acquire ECG, respiratory EMG, ECoG, LFP, and 
bladder pressure reliably. Additionally, the subsystems can be integrated with different 
combinations to arrive at the desired functionality. For instance, two devices with two 
channels of biopotential acquisition were connected to a single powering system and 
simultaneously acquired 4 channels of biopotentials. Chapter 3 presented a miniature, 
fiber-coupled, deep brain optical stimulator for use in optogenetics. This was one of the 





animals. The device offers programmable stimulation parameters and consumes less than 
23 µW during deep sleep operation. The MCU controls the stimulation parameters and as 
such, the optical module can be integrated with the technologies in Chapter 2 for closed-
loop optical stimulation. The device weighs less than 2 g and demonstrated dose-
dependent conditioned place preference (CPP) in transgenic mice. Chapter 4 presented 
the design and characterization of a three-axis RCFET wireless powering cage. This 
WPT system is unique in that it offers a volume (11 x 11 x11 in3) of wireless power that 
can support housing of adult rats. PTE of 1.8-6.28% is achieved, and this can support 
power for 1 to 2 devices presented in chapter 3. Typically, only 1 W of power is needed 
and this is below comparable power transfer systems. Further in vivo validation is 
required, but preliminary results are promising. This work is novel in the breadth of 
technologies presented. Typically, focus is in optimizing a subsystem to achieve 
particular specifications. In this work, full system design, characterization and integration 
are demonstrated. To further advance this platform, future work should focus on 
increased channel counts for acquisition and modulation, integration of all of device 
technologies into a singular form factor, designing modular powering cages for large 
behavioral arenas and housing units, and further miniaturization of all implantable 
technologies.  
A foundational premise of engineering is to use physics and technology to better 
the lives of individuals and societies. This work hopes to contribute to the betterment of 
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Epilepsy affects 1% of the world’s population and one-third of the patients are refractory to 
current anti-epileptic drugs. Electrical neuromodulation techniques—vagus nerve stimulation 
(VNS) and deep brain stimulation (DBS)—offer invasive, but promising paradigms to decrease 
seizure rates.  In particular, closed-loop, responsive DBS at critical brain pathways can be an 
effective method to abolish seizures milliseconds after detection; however, the algorithms, 
electrode placement, and stimulation waveforms must be optimized to target specific populations 
of neurons. Optogenetics offers increasing spatial and molecular resolution to modulate and 
discover brain microcircuits by delivering opsins that are sensitive to specific wavelengths of 
light to selective neurons. The promise of optogenetics could be realized by “turning off” large 
populations of diseased neurons with optical stimulation shortly after detecting a seizure. While 
engineering of devices can improve their efficacies, the agglomeration of neurobiology, disease 
pathology, and physiological mechanisms of electrical and optical stimulation should drive the 
new generation of implantable devices. My interests lie in this vast and largely unexplored 
horizon. Specifically, I am interested in full system architectures of devices, low power control 
algorithms, and pairing traditional transistor based tools with molecular tools. Additionally, I am 
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Skill sets 
• Altium Designer—printed circuit board design and testing 
• Matlab programming 
• Labview programming 
• Embedded systems – firmware programming 
• Bandpass filter radiofrequency powering 
• Rodent surgery 
• Electrical stimulation paradigms 






 Center for Implantable Devices, Major advisor: Professor Pedro Irazoqui 
 Weldon School of Biomedical Engineering 
 Purdue University, West Lafayette, IN July 2010-May 
2015 
• Designed an implantable, wireless closed-loop electrical DBS research device 
• Designed a skull mounted, deep brain optical stimulator for use in optogenetics 
• Designed an omnidirectional RF wireless powering system for implantable devices 
• Validated all designs in vivo 
 
 Department of Pharmacology, Professor John Jefferys’ Lab 
 University of Oxford, Oxford, England 
 Visiting Researcher June 2014-Nov, 
2014 
• Implanted devices designed at Purdue to study SUDEP 
• Performed acute study to identify DBS brain targets in epilepsy model 
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 Bar Harbor, Maine 
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• Performed chronic optical DBS study in transgenic mice 
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 Purdue University, West Lafayette, IN Summer 2009 
MSTP rotation with Dr. Chang Lu 
• Investigated oil compounds to optimize the separation of cell culture medium into single 
droplets in a soft-lithography microfluidic device 
• The device was intended to separate single cells into single droplets for techniques such as 
single cell electroporation 
  
 Weldon School of Biomedical Engineering 
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MSTP rotation with Dr. Mark Lawley 
• Investigated scheduling algorithms to optimize the amount of extra clinic hours doctors 
should provide to maximize profits and minimize loss of revenue due to patient no-shows 
 
 Biomedical Engineering Summer Internship Program 
 National Institutes of Health Summer 2007 
• 1 of 16 biomedical engineering students selected from the nation 
• Used tandem mass spectrometers to identify and quantify the movement of proteins in 
response to vasopressin in rat renal cells 
• Developed signal processing quality control of elution profiles developed from coupled 
high performance liquid chromatography and mass spectrometry 
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Research Intern in the Wells Center – Dr. Wade Clapp Laboratory 
• Conducted several experiments in vitro to determine effects of  
multi-tyrosine receptor kinase inhibitor, Sutent, on Nf1+/- murine-mast cell function 
• Cultured murine mast cells and fibroblasts 
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• Investigated dielectric properties of adult bone marrow stem cells in vitro 
• Wrote LabVIEW program for solenoid fixture 
• Modeled applied direct currents and magnetic fields to cell culturing device 
• Designed iron core Helmholtz solenoid fixture with flexibility to culture cells 
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• Performed over 20 tests 
• Redesigned, built, and evaluated a specialized test fixture  
• Designed a test fixture to assist measurements of tensile force 
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patient physical exam 
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 Timmy Foundation – Purdue Chapter Aug 2006 – May 
2008 
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